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Background. Transgender and non-binary (TGNB) populations experience disproportionally 
high levels of anxiety and depression; it is imperative we investigate how the COVID-19 
pandemic may have impacted the mental health of TGNB communities.   
 
Methods. Among a Canadian sample of TGNB persons aged 15 years, we used multiple 
linear regression to examine whether interruptions in gender-affirming care were associated 
with anxiety and depression, and whether that effect was modified by pre-pandemic mental 
health.  
 
Results. Anxiety and depression levels were high both pre-pandemic and during the 
pandemic. Approximately a quarter of TGNB persons experienced interruptions in hormonal 
care. After adjusting for confounders, there was no association between interruptions in 
gender-affirming care and anxiety. However, interruptions in hormonal care was associated 
with increased depressive symptoms during the pandemic, and this effect was modified by 
pre-pandemic depression.  
 
Conclusion. Interruptions in hormonal care may have increased depressive symptoms in an 
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Summary for Lay Audience 
The World Health Organization (WHO) declared the coronavirus disease (COVID-19) a 
global health pandemic on March 11th, 2020. Since then, there have been major social, health 
and economic changes. The shut down of “non-essential” businesses contributed to increased 
unemployment rates, school closures forced students and teachers to adapt to a virtual 
learning environment, and disruptions in health-care systems resulted in an increase in unmet 
health care needs. Evidently, the COVID-19 pandemic has resulted in an increasing number 
of disruptions to daily life for individuals globally. This has raised concerns about whether 
these changes have contributed to increased mental health challenges; especially for 
marginalized populations, such as the transgender and non-binary (TGNB) community. 
Given that TGNB Canadians have previously experienced inequities in health care access 
and socioeconomic disadvantages, COVID-19-related disruptions may disproportionally 
affect this population.  
Gender dysphoria is the feeling of distress that some TGNB persons experience due to their 
gender identity differing from their sex assigned at birth. Gender-affirming care is a medical 
intervention that can help alleviate this distress. This type of healthcare is available in 
Canada and it includes treatments such as, puberty blockers, hormone therapy and surgeries. 
Importantly, there have been documented benefits and improvements in mental health, 
including anxiety and depression, after receiving gender-affirming care. 
This thesis used data from Trans PULSE Canada; a study that collected data on the health 
and well-being of Canadian TGNB persons aged 14 years pre-pandemic (2019) and one 
year later, during the pandemic (2020). In this study, we found that TGNB persons were 
experiencing high levels of anxiety and depression symptoms both pre-pandemic and during 
the pandemic. Pandemic anxiety severity was not different from pre-pandemic levels; 
however, depression symptoms during the pandemic were higher compared to pre-pandemic. 
We also found that interruptions in gender-affirming care was not linked to anxiety levels 
during the pandemic. In contrast, interruptions in gender-affirming care, specifically 
interruptions in hormonal care, played a role in increased depression during the pandemic, 
wherein interruptions in hormonal care played a greater role on pandemic depression for 





First, I would like to thank my supervisor, Dr. Greta Bauer, for providing me with 
encouragement, support and knowledge during my time at Western University. I am so 
thankful for the opportunities you have provided me; I have developed my analytical and 
communication skills tremendously and for that, I will always be grateful!  
I would also like to thank Dr. Ayden Scheim for always providing me with guidance and 
valuable feedback throughout my thesis process; your extremely timely email responses are 
very appreciated! Additionally, I would like to thank the faculty and my fellow colleagues in 
the Department of Epidemiology and Biostatistics who made my experience at Western 
University unforgettable.  
A big thank you to all the researchers on both the Trans Youth CAN! and Trans PULSE 
Canada teams for all their hard work! A specials thanks to Dr. Sandra Gotovac who was very 
supportive and always provided valuable guidance for my research assistant work! I would 
also like to thank all the participants who contributed their experiences; without you, this 
research and thesis would not have been possible.  
Finally, a big thank you to my family, friends, and partner for their patience, support and 





Table of Contents 
Abstract ............................................................................................................................... ii 
Summary for Lay Audience ............................................................................................... iii 
Acknowledgments.............................................................................................................. iv 
Table of Contents ................................................................................................................ v 
List of Tables ..................................................................................................................... ix 
List of Figures ..................................................................................................................... x 
List of Appendices ............................................................................................................. xi 
Chapter 1 ............................................................................................................................. 1 
1 Introduction .................................................................................................................... 1 
1.1 Overview of study rationale .................................................................................... 1 
1.2 Thesis objectives ..................................................................................................... 3 
Chapter 2 ............................................................................................................................. 5 
2 Literature Review ........................................................................................................... 5 
2.1 TGNB mental health pre-pandemic ........................................................................ 5 
2.2 Gender affirmation and its role in mental health: social, legal and medical ........... 8 
2.3 COVID-19 pandemic impact ................................................................................ 13 
2.4 Current available research: COVID-19 impact on TGNB mental health, social 
support, service disruptions and gender-affirming medical care .......................... 17 
2.4.1 COVID-19 impact on TGNB mental health ............................................. 17 
2.4.2 COVID-19 impact on social support and mental health services for TGNB 
people ........................................................................................................ 18 
2.4.3 COVID-19 and interruptions in gender-affirming medical care............... 19 
2.4.4 Interruptions in gender-affirming medical care and mental health ........... 20 
2.5 Potential implications of COVID-19 disruptions on TGNB people and their 
mental health ......................................................................................................... 21 




3 Methods ........................................................................................................................ 26 
3.1 Study sample ......................................................................................................... 26 
3.2 Directed acyclic graphs ......................................................................................... 29 
3.3 Study measures ..................................................................................................... 33 
3.3.1 Exposure variables .................................................................................... 33 
3.3.2 Outcome variables .................................................................................... 34 
3.3.3 Descriptive characteristics ........................................................................ 35 
3.3.4 Confounder variables – minimum sufficient set ....................................... 37 
3.3.5 Descriptive variables pertaining to gender-affirming care ....................... 39 
3.4 Data considerations ............................................................................................... 41 
3.4.1 Sample merging and weights .................................................................... 41 
3.4.2 Missing data .............................................................................................. 41 
3.5 Statistical Analysis ................................................................................................ 43 
3.5.1 Objectives 1 and 2: descriptive statistics .................................................. 43 
3.5.2 Objective 3: differences in anxiety and depression from pre-pandemic to 
pandemic periods ...................................................................................... 44 
3.5.3 Objective 4: relationship between interruptions in gender-affirming 
medical care and pandemic anxiety levels ................................................ 45 
3.5.4 Objective 5: relationship between interruptions in gender-affirming 
medical care and pandemic depression levels .......................................... 46 
Chapter 4 ........................................................................................................................... 48 
4 Results .......................................................................................................................... 48 
4.1 Objective 1: descriptive characteristics of the sample .......................................... 48 
4.1.1 Descriptive characteristics of the total sample population ....................... 48 
4.1.2 Descriptive characteristics by interruptions in gender-affirming care 
groupings................................................................................................... 50 
4.2 Objective 2: describing interruptions in gender-affirming medical care during the 




4.3 Objective 3: paired sample t-test analyses for anxiety and depression ................. 57 
4.4 Objective 4: regression analyses of interruptions in gender-affirming care and 
anxiety ................................................................................................................... 59 
4.4.1 Model 1— interruptions in gender-affirming medical care as a predictor of 
pandemic anxiety (adjusting for pre-pandemic anxiety) .......................... 59 
4.4.2 Model 2— interruptions in gender-affirming medical care as a predictor of 
pandemic anxiety, assessing for an interaction between interruptions in 
care and pre-pandemic anxiety levels and adjusting for other potential 
confounders ............................................................................................... 60 
4.4.3 Model 3— interruptions in gender-affirming medical care as a predictor of 
pandemic anxiety, adjusting for pre-pandemic anxiety and other potential 
confounders ............................................................................................... 60 
4.5 Objective 5: regression analyses of interruptions in gender-affirming care and 
depression ............................................................................................................. 62 
4.5.1 Model 1— interruptions in gender-affirming medical care as a predictor of 
pandemic depression (adjusting for pre-pandemic depression) ................ 62 
4.5.2 Model 2—— interruptions in gender-affirming medical care as a predictor 
of pandemic depression, assessing for an interaction between interruptions 
in care and pre-pandemic depression and adjusting for other potential 
confounders ............................................................................................... 63 
4.5.3 Model 3— interruptions in gender-affirming medical care as a predictor of 
pandemic depression, adjusting for pre-pandemic depression and other 
potential confounders ................................................................................ 65 
Chapter 5 ........................................................................................................................... 66 
5 Discussion .................................................................................................................... 66 
5.1 Summary of results ............................................................................................... 66 
5.1.1 Changes in anxiety and depression symptoms from pre-pandemic to 
pandemic periods ...................................................................................... 66 
5.1.2 Descriptive characteristics of the sample population ................................ 68 
5.1.3 Descriptive characteristics by interruptions in gender-affirming care 
groupings................................................................................................... 69 
5.1.4 Interruptions in gender-affirming care during the COVID-19 pandemic . 70 





5.1.6 Regression analyses of interruptions in gender-affirming care and 
depression ................................................................................................. 75 
5.2 Strengths and limitations....................................................................................... 76 
5.3 Future research ...................................................................................................... 80 
References ......................................................................................................................... 82 
Appendices ...................................................................................................................... 102 




List of Tables 
Table 1 Missingness for the confounder variables ................................................................. 42 
Table 2 Characteristics of the participants in the analytic sample (N=611) ......................... 49 
Table 3 Characteristics of TGNB individuals experiencing interruptions in gender-affirming 
medical care during the COVID-19 pandemic stratified by type of interruption ................... 53 
Table 4 Gender-Affirming Care Status and Interruptions in Care due to COVID-19 (N=611)
................................................................................................................................................. 56 
Table 5 Pre-pandemic and pandemic anxiety and depression statistics ................................ 58 
Table 6 Paired t-test assessing the difference in anxiety and depression scores from pre-
pandemic to pandemic periods ............................................................................................... 59 
Table 7 Anxiety regression models (N=611) .......................................................................... 61 





List of Figures 
Figure 1  Directed acyclic graph (DAG) of the relationship between interruptions in gender-







List of Appendices 






Chapter 1  
1 Introduction 
This chapter will explain the rationale and study objectives for this thesis. 
1.1 Overview of study rationale 
The World Health Organization (WHO) declared the coronavirus disease (COVID-19) a 
global health pandemic on March 11th, 2020 (WHO, 2020b). Within a short period of 
time, COVID-19 has had detrimental health effects on millions of individuals, notably 
among older adults and those with pre-existing medical conditions. As morbidity and 
mortality rates continue to be monitored globally, broader impacts of COVID-19 have 
also been recognized, such as disruptions in healthcare systems, social gatherings and 
events, and economic strain (Haleem et al., 2020). At the beginning of the pandemic, 
many countries opted to shut down “non-essential” businesses; consequently, 
unemployment rates increased significantly. In Canada alone, the economic shutdown 
resulted in the unemployment rate increasing more than two-fold from 5.6% in February 
to 13.7% in May of 2020 (Statistics Canada, 2020a). School closures forced students to 
learn from home via an online format, and stay-at-home orders along with social 
gathering limits were implemented to slow down the spread of the virus, resulting in 
individuals social distancing from peers and even close family members. Moreover, due 
to the potential influx of COVID-19 patients in hospitals and scarce medical resource 
availability, non-urgent medical care were put on hold or delayed for many individuals, 
resulting in an increase in unmet health care needs (Canadian Agency for Drugs and 
Technologies in Health, 2020). These additional, indirect burdens of the COVID-19 
disease have affected the lives of individuals in other ways, alongside physical health 
(Dubey et al., 2020).  
As SARS-CoV-2 is a novel viral strand that has not been previously identified (WHO, 
2020b), it has resulted in an abundance of research being conducted on the development 
of a treatment for infected patients, in addition with how to best advise the public on 
strategies to prevent the spread of infection (Banerjee & Nair, 2020; Sirotich & 
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Hausmann, 2021). Given the race to vaccinate populations and the focus on mitigating 
the spread of the virus, there has been limited research efforts on how the COVID-19 
pandemic has impacted minority populations.  In particular, sexual and gender minority 
populations (SGM) are underrepresented (Phillips et al., 2020; Sirotich & Hausmann, 
2021). The impact of the virus itself is largely unknown among the transgender and non-
binary (TGNB) population due to the lack of inclusion of sexual orientation and gender 
identity in surveillance data (Phillips et al., 2020). Efforts to mitigate the impacts of 
COVID-19, including health care interruptions and socioeconomic disruptions are being 
experienced across Canada (Chen-See, 2020; Statistics Canada, 2020b). However, these 
disruptions may be particularly severe for TGNB Canadians given pre-existing inequities 
in health care access and socioeconomic disadvantages (Bauer & Scheim, 2015). In the 
U.S., it was reported that 13.1% of the lesbian, gay, bisexual and transgender (LGBT) 
adult population experienced food insecurity due to the pandemic, compared to 7.2% of 
adults who were not LGBT (File & Marshall, 2021). The U.S. Census Bureau Survey 
data also revealed that LGBT persons experienced greater economic struggles than their 
non-LGBT counterparts. Therefore, there is evidence to suggest that inequities are being 
further magnified by the COVID-19 pandemic.  
There has also been an increase in unmet health care needs due to the delay in non-urgent 
medical care. These delays have also affected TGNB persons due to the postponement of 
in-person consultation and surgeries. As a result, there may be an increased difficulty 
accessing hormone therapy and/or gender-affirming surgeries during the pandemic 
(Wang et al., 2020). Even prior to the pandemic, many TGNB persons seeking gender-
affirming medical care have had to overcome obstacles to schedule their appointments 
and surgical procedures, including financial, legal and geographic barriers (Roberts et al., 
2020). The usual wait times that are experienced can be even further exacerbated due to 
the pandemic. Moreover, previous research has demonstrated that TGNB communities 
already experience increased health and mental health concerns compared to the general 
and lesbian, gay, and bisexual (LGB) populations (Grant et al., 2011; Su et al., 2016), 
which becomes increasingly concerning with the impacts of COVID-19. Given that 
gender-affirming care has repeatedly demonstrated improvements in mental health 
outcomes in TGNB persons (Baker et al., 2021; Passos et al., 2020; Wernick et al., 2019; 
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White Hughto & Reisner, 2016), it is imperative we investigate whether difficulties in 
accessing gender-affirming care during the pandemic have impacted the mental health of 
this population.  
In general, there is limited research on the effects of delays to gender-affirming care due 
to COVID-19 on TGNB peoples’ mental health. The majority of the current literature 
consists of perspectives, commentaries and opinion pieces on sex and gender equity 
issues, with few primary and secondary studies that have investigated the effects of the 
COVID-19 pandemic on TGNB peoples’ mental health. In Canada, no major health 
survey has captured the experiences of lesbian, gay, bisexual, transgender, queer (or 
sometimes questioning), and two-spirited (LGBTQ2+) Canadians during the pandemic 
(Prokopenko & Kevins, 2020). Therefore, it is evident that there is a gap in the current 
literature on the impact of pandemic-related delays in gender-affirming care on TGNB 
mental health in Canada. Fortunately, the Trans PULSE Canada study is a community-
based survey that has collected data on TGNB health and well-being both pre-pandemic 
and during the pandemic. This provides a unique opportunity to conduct a longitudinal 
study that can fill the current gap in literature and shed light on some of the impacts that 
the COVID-19 pandemic has had on TGNB individuals in Canada.  
1.2 Thesis objectives 
The purpose of this thesis is to determine the impact of interruptions in gender-affirming 
medical care during COVID-19 on anxiety and depression levels among TGNB persons 
in Canada. The following objectives will be addressed:  
 
1. Identify the characteristics of TGNB persons in Canada at the time of the 
COVID-19 pandemic, as well as the characteristics of TGNB individuals 
experiencing interruptions in gender-affirming medical care during the pandemic. 
 
2. Describe interruptions in gender-affirming medical care during the COVID-19 




3. Identify if there are differences in anxiety and depression levels among TGNB 
individuals from pre-pandemic to pandemic periods.   
 
4. Examine if there is a relationship between interruptions in gender-affirming 
medical care and pandemic anxiety levels. 
 
a. Model 1— interruptions in gender-affirming medical care as a predictor of 
pandemic anxiety, adjusting for pre-pandemic anxiety. 
 
b. Model 2— interruptions in gender-affirming medical care as a predictor of 
pandemic anxiety, assessing for an interaction between interruptions in 
care and pre-pandemic anxiety levels and adjusting for other potential 
confounders. 
 
c. Model 3— interruptions in gender-affirming medical care as a predictor of 
pandemic anxiety, adjusting for pre-pandemic anxiety and other potential 
confounders. 
 
5. Examine if there is a relationship between interruptions in gender-affirming 
medical care and pandemic depression levels. 
 
a. Model 1— interruptions in gender-affirming medical care as a predictor of 
pandemic depression, adjusting for pre-pandemic depression. 
 
b. Model 2—  interruptions in gender-affirming medical care as a predictor 
of pandemic depression, assessing for an interaction between interruptions 
in care and pre-pandemic depression levels and adjusting for other 
potential confounders.  
c. Model 3— interruptions in gender-affirming medical care as a predictor of 




Chapter 2  
2 Literature Review 
The following chapter will provide an overview of TGNB mental health pre-pandemic 
and the role of gender affirmation (social, legal and medical) in mental health with a 
specific focus on gender-affirming medical care. It will also briefly review the literature 
that is available on the global impact of COVID-19 and how changes related to the 
pandemic may play a role in the lives of TGNB people. Finally, this review will discuss 
the current available research on TGNB mental health during the COVID-19 pandemic, 
as well as the implications of interruptions in gender-affirming medical care on TGNB 
mental health. 
2.1 TGNB mental health pre-pandemic   
Sex assigned at birth is the assignment of male or female to an infant based on the 
appearance of the genitalia at birth. Gender differs from biological sex in the sense that it 
is used to describe the socially constructed and accepted roles, behaviours, expressions 
and identities of individuals, which can change over time (Canadian Institutes of Health 
Research, 2020). One’s gender identity may be the same or different from their sex 
assigned at birth. Cisgender denotes persons whose gender identity is congruent with 
their biological sex. In contrast, transgender is an umbrella term used to describe 
individuals whose gender identity does not align with their sex assigned at birth (GLAAD 
Media Reference Guide, 2016). This includes persons who identify as women, men, non-
binary, genderqueer, cross-dresser, transexual, along with other gender identities. 
Individuals whose gender identity does not simply fit into the two categories, man or 
woman, may identify themselves as non-binary or genderqueer (GLAAD Media 
Reference Guide, 2016). 
Prior to the onset of the current pandemic, TGNB adults and adolescents were already 
experiencing disproportionally high levels of anxiety, depression, and suicidal thoughts 
(Becerra-Culqui et al., 2018; Kattari et al., 2020). Multiple studies have reported 
depression prevalence rates ranging from 50% to 67% (Clements-Nolle et al., 2006; Kim 
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et al., 2006; Nuttbrock et al., 2010). In comparison, in the Canadian general population, 
the prevalence of depression is 4.7% (Pearson et al., 2013). This highlights the 
importance of attending to the mental health needs of this population. Canadian studies 
using clinical samples have reported that TGNB persons may be experiencing high levels 
of anxiety and depression. A recent retrospective chart review of TGNB persons referred 
to a transgender clinic in Kingston, Ontario reported that almost two thirds of the clinical 
sample was diagnosed with an anxiety disorder in their lifetime and just over half of the 
sample was diagnosed with mood disorders (She et al., 2020). Another Canadian clinical 
study of TGNB youth in Vancouver reported that 24% and 35% of their sample had an 
anxiety disorder and mood disorder, respectively (Khatchadourian et al., 2014).  
Other countries, such as the U.K. and U.S, have also reported a high prevalence of 
anxiety, depression, suicide and self-harm in clinical samples of TGNB persons. A U.S. 
retrospective cohort study that used electronic medical records of transgender youth 
matched with cisgender counterparts revealed mental health disparities between the two 
populations (Reisner et al., 2015). This study revealed that transgender youth had a 
greater risk of being diagnosed with anxiety (RR: 3.27; 95% CI: 1.80, 5.95) and 
depression (RR: 3.95; 95% CI: 2.60, 5.99), compared to their matched cisgender peers. A 
study in the UK investigated levels of depression among a large clinical sample of TGNB 
persons who had been referred to a national transgender health service (Witcomb et al., 
2018). Among TGNB persons who were not currently on hormone therapy, the risk of a 
possible depressive disorder or probable depressive disorder was four times higher in 
TGNB persons compared to the general UK population (Witcomb et al., 2018). However, 
it is important to note that clinical samples might not provide the most accurate 
representation of mental health for TGNB persons in the community. Clinical samples 
might overrepresent the proportion of TGNB persons experiencing mental health 
challenges since mental health or inability to cope would likely lead these individuals to 
make the decision to clinically address their gender dysphoria.  
Heightened mental health challenges have also been reported in non-clinical samples of 
TGNB Canadians. The Trans PULSE Project, a community-based research project, 
reported that approximately 61.2% of transfeminine individuals experienced symptoms 
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that could be classified as having clinical depression (Rotondi, Bauer, Travers, et al., 
2011). The Trans PULSE Project also reported that the prevalence of depression was 
similar for transmasculine individuals, with about two-thirds reporting symptoms that are 
consistent with a clinical depression diagnosis (Rotondi, Bauer, Scanlon, et al., 2011). 
Moreover, rates of suicidal ideation and attempts were high in transgender Ontarians 
where 35.1% reported suicidal ideation and 11.2% attempted suicide in the past year 
(Bauer et al., 2015). Similarly, the Canadian Trans Youth Health Survey revealed a 
heightened prevalence of mental health challenges in youth and young adults across 
Canada (Veale, Peter, Travers, et al., 2017). Among TGNB youth aged 14-18, almost 
75% reported non-suicidal self-injury in the past year, about 35% reported a suicide 
attempt in the past year and 45% reported extreme stress. Among TGNB young adults 
aged 19-25, over half of the respondents reported non-suicidal self-injury in the past year, 
close to 75% reported having ever seriously considered suicide and 71% reported feeling 
depressed in the past year (Veale, Peter, Travers, et al., 2017). One Canadian study noted 
significant mental health disparities when comparing the mental health of TGNB persons 
to the general population in Canada that were matched on age. Among those aged 19 to 
25 years, greater psychological distress was reported for TGNB individuals when 
compared to a general population of young adults from the Canadian Community Health 
Survey (Veale, Watson, Peter, et al., 2017). Moreover, compared to the general 
population of youth, there was also a significantly greater proportion of TGNB 
individuals who reported a major depressive episode in the past year (71.1% vs. 7.8%), 
suicidal ideation in their lifetime (74.4% vs 15.4%), and suicide attempts in their lifetime 
(37.8% vs. 3.4%). When comparing gender identities, self-harm was reported more often 
in non-binary and transmasculine individuals, with non-binary persons reporting worse 
levels of mental health overall (Veale, Watson, Peter, et al., 2017). Suicide and self-harm 
may be fatal and/or harmful consequences of anxiety and depression in the TGNB 
community. As previously discussed, the prevalence of depression is much higher in the 
TGNB population compared to the general population in Canada. The same trend seems 
to follow for anxiety disorders. Jaffray (2020) reported that Canadian TGNB persons 
were more likely to be diagnosed with an anxiety disorder than Canadian cisgender 
persons (57.0% vs. 13.1%). This demonstrates that TGNB persons in Canada are likely 
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experiencing a disproportionally high level of pre-pandemic mental health challenges 
compared to other Canadian populations. 
Several community-based studies in other countries have also found similar mental health 
trends in their TGNB communities. An online survey that was conducted in Australia and 
New Zealand investigated the health and well-being of TGNB communities (Pitts et al., 
2009). The study revealed that 36.2% of TGNB persons had depressive symptoms that 
were indicative of a current major depressive disorder. The prevalence of depression 
found in this sample of TGNB individuals was also much higher relative to the general 
Australian population where 6.2% of Australians experienced an affective disorder in a 
12-month period (Australian Bureau of Statistics, 2007). Another study used a national 
community sample to investigate the mental health and well-being of TGNB youth aged 
14 to 25 across Australia (Smith et al., 2014). This study reported that 45% and 47% of 
the participants reported an anxiety and depression diagnosis, respectively. A 
community-based study with TGNB participants from the UK and Ireland reported 
similar mental health challenges (McNeil et al., 2012). This study revealed that 63% of 
their sample had suicidal ideation in the past year and 11% had attempted suicide in the 
past year. Anxiety and depression levels were also concerning with 55% and 38% 
reporting having had/currently having a depression and anxiety diagnosis, respectively 
(McNeil et al., 2012). The 2015 U.S. Transgender Survey reported that 39% of TGNB 
persons experienced psychological distress compared to 5% of the general U.S. 
population (James et al., 2016). Therefore, a heightened prevalence of mental health 
challenges has been noted in TGNB populations with significant differences relative to 
the general population. This raises concerns about whether the COVID-19 pandemic is 
further exacerbating anxiety and depressive symptomology in TGNB individuals 
2.2 Gender affirmation and its role in mental health: social, 
legal and medical 
Gender affirmation is the social acceptance and recognition of an individuals’ gender 
identity, role, and/or expression (Sevelius, 2013). A TGNB person’s transition may have 
social, legal and/or medical aspects in which some or all can contribute to an individuals’ 
gender affirming process. Social gender affirmation might include things like “coming 
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out”, the correct use of preferred names and pronouns, social support from friends, family 
and/or strangers, and dressing in clothing that expresses one’s gender identity (Glynn et 
al., 2016). Previous research has shown that social gender affirmation has an impact on 
the health and well-being of TGNB persons. A U.S. study examined the association 
between gender affirmation and psychological well-being and determined that 
transgender women with family support had lower levels of depression and higher self-
esteem (Glynn et al., 2016). These findings remain consistent among other studies where 
there have been positive mental health outcomes and lower levels of anxiety and 
depression found in transgender persons who have social support (Ryan et al., 2010; 
Murdock & Bolch, 2005). In contrast, TGNB individuals who were experiencing high 
levels of family rejection exhibited more depressive symptoms, suicidal ideation and 
attempts, and substance misuse (Yadegarfard et al., 2014; Klein & Golub, 2016). 
Furthermore, the use of preferred names and pronouns can have many positive 
implications on TGNB mental health. A U.S. study of 129 transgender and gender 
diverse youth reported that those who had the ability to use their preferred names had 
lower levels of depression and suicidal behaviours (Russell et al., 2018). Using correct 
preferred names and pronouns allows TGNB persons to feel supported in their felt gender 
while also decreasing stress levels; ultimately resulting in better mental health outcomes 
(Brown et al., 2020).  
Legal gender affirmation refers to making changes to legal documentation (e.g., birth 
certificate, passport, driver’s license) to reflect an individual’s current gender identity. 
Some TGNB persons continue to face difficulties when seeking legal documentation 
changes. For example, in the U.S., some states require medical documentation from a 
doctor/psychiatrist as well a history of gender-affirming medical care (e.g., use of 
hormones and/or surgery) to receive approval for a name change (Restar et al., 2020). In 
Ontario, when requesting a change in sex designation on birth certificates, medical 
documentation from a physician or psychologist is required to support the application 
(Service Ontario, 2021). However, gender-affirming surgeries are not required to apply 
for gender marker or name changes on legal documents across Canada. This 
demonstrates that countries and/or regions may have different existing policies when it 
comes to legal gender affirmation.  
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It is important for TGNB persons to have access to gender congruent identity documents 
as it may impede their daily lives in multiple aspects, including their ability to travel, 
seek employment opportunities, and access social and healthcare services (Malta et al., 
2020). If access is restricted, it may result in TGNB individuals living in social isolation 
or even avoiding necessary medical care, which could ultimately result in basic human 
rights being unintentionally revoked from this already marginalized population. 
Moreover, previous literature has demonstrated that legal gender affirmation has 
significant implications on mental health among TGNB individuals. A Canadian 
community-based research study revealed that among transgender Ontarians aged 16 and 
over, having at least one identity document corresponding to current gender identity was 
associated with a reduction in past year suicide ideation and attempts (Bauer et al., 2015). 
A recent study based in the U.S. also revealed that compared to those who did not 
undergo legal gender marker and name changes, those who did reported lower levels of 
depression, anxiety and psychiatric distress (Restar et al., 2020). Similarly, a cross-
sectional study conducted in the U.S. reported that compared to those who did not have 
ID’s congruent with their gender, psychological distress and suicidal ideation and 
planning was lower among those who did have all their ID’s congruent with their gender 
(Scheim et al., 2020). This demonstrates that legal gender affirmation may play a 
significant role in TGNB mental health and further emphasizes the importance for policy 
makers to reduce barriers and ease access to legal document changes for TGNB persons.  
Some TGNB persons may experience distress and/or discomfort due to the discordance 
between their gender identity and sex assigned at birth—this is known as gender 
dysphoria (American Psychiatric Association, 2013). Studies have suggested that both 
adolescent and adults experiencing gender dysphoria are increasingly seeking support and 
care at gender identity clinics in both Europe and North America (de Vries et al., 2015; 
Aitken et al., 2015). Fortunately, treatments are available to TGNB persons who are 
experiencing discomfort or distress.  
Gender-affirming medical care is one such treatment that may alleviate symptoms 
through aligning one’s gender identity with their physical appearance. This can be 
attained through using puberty blockers, hormone therapy, and/or surgery. Puberty 
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blockers are sometimes prescribed for adolescents who are experiencing gender 
dysphoria in order to suppress the production of estrogen and testosterone, and ultimately 
delay changes to the body that occur during the pubescent years (World Professional 
Association for Transgender Health [WPATH], 2012). Research has demonstrated that 
the effects of puberty blockers are reversible and safe to administer in children. Hormone 
therapy is used to feminize or masculinize an individuals’ body who is experiencing 
gender dysphoria and is considered a partially reversible treatment (WPATH, 2012). 
Gender-affirming surgeries, such as “top”, “bottom”, and facial surgeries are irreversible 
procedures that are medically necessary for some TGNB persons. In general, not all 
TGNB persons seek gender-affirming medical treatment; some individuals may live as 
their felt gender without any procedures, while others may need one or more gender-
affirming procedures. However, it is important to note that if left untreated, gender 
dysphoria can lead to other mental health complications, including anxiety, depression 
and self-harm behaviours.  
Access to gender-affirming medical care is essential for TGNB persons and can have a 
major impact on their psychosocial well-being. In fact, there has been an increasing trend 
in the number of referrals to gender identity clinics (Fielding & Bass, 2018; Handler et 
al., 2019). A study in the U.K. reported that at a gender clinic located in Oxfordshire, 
referrals had doubled in the past 6 years; there were 59 referrals in 2011-2013 and this 
number increased to 103 referrals from 2014-2016 (Fielding & Bass, 2018). Moreover, 
the mean age of TGNB persons referred to the clinic was significantly lower in more 
recent years (2013-2016) compared to the first three years of the study (2011-2013). A 
study in the U.S. also reported a significant increase in referrals between 2015 and 2018 
where there were 56 referrals in 2015 compared to 194 in 2017 (Handler et al., 2019). 
These findings remain consistent across Canada, where pediatric patient referrals have 
increased exponentially from 2004 to 2016, with about a 10-fold increase from 2012-
2016 (Lawson et al., 2017). Therefore, an increase in demand has been noted in several 




It has already been reported that in British Columbia, TGNB individuals waited 150 days 
or less between their referral and surgery assessment appointment, while TGNB persons 
from other provinces/territories in Canada waited 180 days. Upon completion of this 
appointment, there was another waiting period between surgery approval and the surgery 
date which was eight months or less in Canada (Frohard-Dourlent et al., 2017). Long 
wait-times were previously reported for hormone therapy as well. In Alberta, some 
TGNB individuals have to wait up to six months to find a general practitioner that will 
refer them to a psychiatrist, in which psychiatric wait-lists can then be even longer. There 
is also another three to four month waiting period after to have an appointment with an 
endocrinologist in order to receive a prescription (Rendell-Watson, 2017). 
Several studies have noted the benefits and improvements in mental health outcomes 
upon receiving gender-affirming care (Almazan & Keuroghlian, 2021; Baker et al., 2021; 
Wernick et al., 2019; White Hughto & Reisner, 2016; Passos et al., 2020). A recently 
published systematic review investigated the effects of hormone therapy on mental health 
outcomes and quality of life among TGNB people of all ages (Baker et al., 2021). The 
review concluded that there is evidence to suggest that hormone therapy may improve 
quality of life, anxiety symptoms, and depressive symptoms among TGNB persons, with 
no studies reporting negative psychological outcomes due to hormone therapy. This 
finding was consistent across gender identities and age (Baker et al., 2021). Another 
systematic review by Wernick et al. (2019) found that gender-affirming surgeries 
provided improvements in psychological outcomes as well. 
Furthermore, a study conducted in the Netherlands concluded that hormone therapy and 
gender reassignment surgery significantly reduced gender dysphoria symptoms and 
improved psychological outcomes (including anxiety and depression) in young adults 
over time (de Vries et al., 2014). Importantly, it was reported that after gender-affirming 
surgery, the wellbeing of TGNB persons in this study was similar or in some cases, even 
better than that of the general population within the same age range (de Vries et al., 
2014). A study conducted in the U.S. examined the relationship between gender-
affirming surgeries and mental health outcomes in a large sample of TGNB adults 
(Almazan & Keuroghlian, 2021). The results suggested that having had one or more 
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gender-affirming surgeries was associated with reduced psychological distress in the past 
month, as well as lower past year suicidal ideation. A Canadian study by Bauer et al. 
(2015) determined that among transgender persons who reported a need to receive 
gender-affirming care, those who completed a medical transition (such as hormone 
therapy and/or surgical procedures) had reduced suicidal ideation. A community sample 
from the UK and Ireland also reported that suicidal ideation and attempts were reduced 
after receiving gender-affirming care with 70% of TGNB persons reporting they were 
more satisfied with their lives post transition (McNeil et al., 2012). Moreover, a 
prospective cohort study conducted in Italy reported that hormone therapy was associated 
with better mental health, in which both anxiety and depression was reduced for those 
who were using hormone therapy (Colizzi et al., 2014). Therefore, several studies in 
various countries have determined that there is a relationship between gender-affirming 
care and improved mental health, including anxiety and depression, in TGNB persons 
who require this form of care. 
2.3 COVID-19 pandemic impact 
On December 31st, the WHO was notified of cases of pneumonia with an unknown cause 
discovered in Wuhan City, China (WHO, 2020b). The number of new cases continued to 
increase rapidly and COVID-19 began spreading to various countries in a very short 
period of time. On March 11th 2020, the WHO declared COVID-19 a global pandemic. 
In the early months of the pandemic, government policy responses were very similar 
world-wide (Hale et al., 2021). Most countries established various emergency measures 
to mitigate and reduce the spread of COVID-19. It is important to note how quickly 
governments had adopted these new policies. Hale et al. (2021) revealed that in early 
March, extreme lockdown measures had not been implemented in the majority of 
countries worldwide. However, by the beginning of April, the policy response of almost 
every single country changed drastically; lockdown orders and new measures to curb the 
spread of COVID-19 were quickly adapted globally. These measures resulted in changes 
to day-to-day functioning for almost all individuals and led to disruptions world-wide, 
including travel restrictions, increased contact tracing and quarantine requirements, 
increased investment in medical equipment for healthcare facilities, reduced or cancelled 
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healthcare services, workplace/business and school closures, bans on social 
gatherings/events (e.g., weddings, concerts, sporting events), increased financial support 
for those who may have lost their source of income and overall detrimental economic 
impacts. In the next few months of the pandemic, these policies were eventually lifted or 
eased in some countries however, in some instances, they had been reimposed; especially 
when a resurgence of cases was of concern.  
The closure of businesses and workplaces, including restaurants, fitness facilities and 
retail stores, resulted in a financial loss for both business owners and their employees. To 
mitigate the impact of these changes, some countries offered these businesses and their 
employees financial aid. Specifically, in Canada, the Canada Emergency Response 
Benefit (CERB) provided $2000 monthly to individuals who were directly impacted by 
the COVID-19 pandemic. As the pandemic progressed, other forms of financial support 
were provided to businesses and individuals who were directly impacted by the policies 
that were imposed throughout 2020 and 2021 (Government of Canada, 2021). Support for 
individuals and families included the Employment Insurance Program, Canada Recovery 
Benefit, Canada Recovery Sickness Benefit, among others. The Canadian Government 
also waived interest fees for students who had received federal loans. Additionally, 
school closures resulted in students and teachers having to quickly adapt to learning and 
teaching in an online format. Remote learning introduced other concerns and challenges 
including, family violence and safety, food insecurity, availability of devices and internet 
for children learning from home, and potential income impacts for parents who had to 
reduce their work hours to support homeschooling (Statistics Canada, 2021b).  
The COVID-19 pandemic also had an impact on the delivery of healthcare services. 
Some health services that were previously provided in person were recommended to be 
moved to an online format to mitigate the spread of the virus, such as follow-up visits 
with physicians and psychological treatments, including support groups (WHO, 2020a). 
Additionally, due to the potential influx of patients presenting to emergency departments 
with COVID-19, there was an increased fear of hospital overcrowding. As a result, 
elective procedures and surgeries had largely been cancelled (WHO, 2020a). “Essential” 
health services were still being provided during this time in which the WHO identified 
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priority categories and/or populations; this included but was not limited to immunizations 
for communicable diseases, reproductive health services, services for vulnerable 
populations (e.g., children and older adults), medications and services for the 
management of chronic diseases, and acute health emergencies that require immediate 
attention. Over a year into the pandemic, it was reported that 90% of countries were still 
experiencing at least one interruption in essential healthcare services, which indicated no 
major changes since the beginning of the pandemic (WHO, 2021).  
The Canadian healthcare system also endured changes due to the COVID-19 pandemic 
(Canadian Institute for Health Information [CIHI], 2020). For example, emergency 
department visits, hospital care and physician services were largely affected. In 
particular, there was a tremendous number of surgery cancellations reported which 
directly impacted Canadians. From March to June 2020, there were approximately 335 
000 fewer surgeries performed in Canada in comparison to the previous year (CIHI, 
2020). Those who required medically urgent surgeries were likely to receive them as 
planned however, there was a reduction in surgeries that were deemed less urgent. 
Compared to the same time period in 2019, the first few months of the pandemic in 2020 
resulted in a decrease in surgeries; this included 21% fewer knee and hip replacements, a 
53% reduction in hernia repairs, 29% fewer retina repairs and 17% lower fracture repairs 
(CIHI, 2020). There was also a disruption in cancer care in which there was a 20% 
reduction in cancer surgeries performed during the first wave of the pandemic compared 
to the same time frame in 2019. Moreover, Chen-See (2020) reported that approximately 
50% of those receiving cancer care had their appointments cancelled or rescheduled due 
to COVID-19 in Canada.  
Disruptions in healthcare services likely impacted TGNB persons in Canada with regards 
to gender-affirming care. It was reported that gender-affirming surgeries were cancelled 
during the first wave of the pandemic (Provincial Health Services Authority [PHSA], 
2020). By June of 2020, some elective surgeries had recommenced in hospitals and this 
varied by province/territory (CIHI, 2020). Similarly, some gender-affirming surgeries 
were resumed during this time as well (PHSA, 2020). It is important to note that prior to 
the pandemic, there were already long wait-times for gender-affirming surgeries 
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(Frohard-Dourlent et al., 2017). As a result, the COVID-19 pandemic will only 
exacerbate the pre-existing wait-times and impact future surgeries. A recent brief report 
by the Trans PULSE Canada study noted that TGNB persons in Canada also experienced 
interruptions in their hormonal care due to the COVID-19 pandemic (Trans PULSE 
Canada COVID Cohort Working Group on behalf of the Trans PULSE Canada Team, 
2020). Therefore, the postponement of non-urgent healthcare services likely had an 
impact on the availability of gender-affirming care for TGNB persons in Canada.  
Similar to other emergency and crisis events, it is inevitable that there will be 
psychological consequences due to the increased distress experienced from the COVID-
19 pandemic (WHO, 2019). Each individual may be impacted differently during a state 
of emergency. In particular, the WHO (2019) reported that during humanitarian crises, 
including epidemics, it is common to see anxiety and depression levels increase over two-
fold. Vulnerable populations who already experience severe mental disorders can be 
disproportionally affected during and after emergency events; emphasizing the 
importance of providing access to care for these individuals.  
In Canada, there have already been increased concerns for the mental health of Canadians 
amidst the pandemic. A report by the Canadian Mental Health Association (CMHA) 
revealed that during the first wave of the pandemic, 38% of Canadians said that their 
mental health worsened due to COVID-19 with 46% feeling anxious and worried 
(CMHA, 2020a). Moreover, people who identified as LGBTQ2+ were more likely to 
report a decline in mental health during this time period. Another study by CMHA that 
took place during the second wave of the pandemic revealed that Canadians were still 
experiencing heightened mental health challenges in certain subpopulations (CMHA, 
2020b). Specifically, LGBTQ2+ individuals were experiencing increased mental health 
challenges in comparison to the first wave of the pandemic (CMHA, 2020b). There are 
several reasons why COVID-19 may be contributing to rising mental health issues in 
Canadians. Some of these mental health challenges may be attributed to the uncertainty 
about this novel virus, including an increased concern for one’s health, as well as the 
health of other family members or loved ones, while other challenges may be attributed 
to the policy changes. For example, due to mandated industry closures, some may be 
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experiencing unemployment or income loss, school closures may result in the loss of a 
safe and supportive environment for some students, and stay-at-home orders may result 
in increased social isolation and domestic violence (CMHA, 2020c). 
2.4 Current available research: COVID-19 impact on TGNB 
mental health, social support, service disruptions and 
gender-affirming medical care  
2.4.1 COVID-19 impact on TGNB mental health 
The current literature has shown that TGNB youth have generally been experiencing 
heightened mental health problems in relation to the COVID-19 pandemic (Hawke et al., 
2021; Jones et al., 2021). In particular, increased anxiety and depression levels have most 
often been reported. A Canadian study with a sample of 622 youth (29 identified as 
TGNB and 593 identified as a man/boy or woman/girl) reported that TGNB youth had 
significantly higher scores for mental health issues during COVID-19 compared to their 
cisgender counterparts (OR=2.64, p-value=0.001) (Hawke et al., 2021). In the U.K., 161 
TGNB youth participated in an online survey where they could describe their personal 
experiences during COVID-19 via open-response questions (Jones et al., 2021). The 
qualitative portion of the survey revealed that several youths had reported that their 
anxiety and depression symptoms were exacerbated during the beginning of the 
pandemic. However, there were also a small sample of youth that noted that their mental 
health symptoms had improved due to the pandemic, most notably due to having more 
free time to work on their mental health as well as having reduced social anxiety (Jones et 
al., 2021).  
TGNB adults have also been experiencing deteriorating mental health amidst the 
pandemic. A global cross-sectional survey of TGNB adults (n=849) reported that 
approximately 46% and 51% of their sample screened positive for anxiety and 
depression, respectively (Restar et al., 2021). The U.S. PRIDE longitudinal study also 
discovered depression and anxiety changes among SGM persons during the onset of the 
COVID-19 pandemic (Flentje et al., 2020). For the 2288 participants included in the 
study, depression symptoms increased by a Patient Health Questionnaire-9 (PHQ-9) 
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score of 1.21 (t=11.35, p value <0.001) from pre- to post-pandemic. Anxiety symptoms 
also increased by a General Anxiety Disorder-7 (GAD-7) score of 3.11 (t=27.95, 
p<0.001) from pre- to post-pandemic. Interestingly, those who were not experiencing 
symptoms consistent with generalized anxiety and depression pre-pandemic were the 
individuals who were experiencing these increased anxiety and depression symptoms 
post-pandemic (Flentje et al., 2020). Another U.S. study reported that compared to pre-
pandemic anxiety and depression levels, a greater proportion of TGNB individuals met 
the threshold for clinically significant symptoms of anxiety and depression during the 
pandemic (Kidd et al., 2021).  Importantly, a recent study on LGBTQ+ adults in the U.K. 
has shown that TGNB individuals reported higher depression scores than their cisgender, 
lesbian and gay counterparts during the pandemic (Kneale & Bécares, 2021). Therefore, 
there is evidence to suggest that TGNB persons are experiencing mental health 
complications amidst the pandemic—further emphasizing the importance of including 
TGNB persons in COVID-19-related research efforts. 
2.4.2 COVID-19 impact on social support and mental health services 
for TGNB people 
Studies have reported that TGNB persons are experiencing a lack of social support during 
the pandemic (Hawke et al., 2021; Jones et al., 2021). A Canadian study by Hawke et al. 
(2021) determined that TGNB youth are experiencing a lack of support from family 
members during the pandemic, however this trend was not reported when examining 
levels of support from friends or significant others. The authors concluded that this may 
be as a result of living in unsupportive environments due to stay-at-home orders that have 
been implemented (Hawke et al., 2021). Similarly, another study in the U.K. reported that 
youth had lost sources of support and had challenges accessing support due to social 
distancing guidelines (Jones at al., 2021). TGNB adults are also experiencing disruptions 
regarding the social support they usually have available. The predominately European, 
TransCareCOVID-19 study reported that of participants who were members of a support 
group, 69.2% had limited access to them due to COVID-19 (Koehler et al., 2020).  
The COVID-19 pandemic has also resulted in several service disruptions due to stay-at-
home orders. For the TGNB population, mental health service disruptions as well as 
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reduced access to community support groups have been reported. Among TGNB 
Canadian youth, approximately 70% reported a COVID-19-related disruption in mental 
health or substance use service compared to 26% of cisgender youth (Hawke et al., 
2021). Moreover, a greater proportion of TGNB youth reported that their needs were not 
met for mental health and substance use services compared to cisgender youth (63% vs. 
28%). Although telehealth has become widely adapted in the COVID-19 era, it is 
important to note that telehealth mental health services may not be ideal for TGNB 
persons as they might experience social anxiety (e.g., in relation to their voice) which 
prevents them from using online mental health interventions (Jones et al., 2021).  
A cross-sectional global study of 964 TGNB adults reported that among gender-affirming 
resources that they were using, mental health services was the most frequently disrupted 
resource (Jarrett et al., 2021). Some TGNB persons rely on other services for informal 
mental health support, for which it has been reported that there is also reduced access to 
specific LGBTQ+ and TGNB supportive organizations due to the pandemic (Kidd et al., 
2021). A U.S. longitudinal cohort study of TGNB adults showed that over half of their 
study sample had reduced access to LGBTQ+/TGNB supportive organizations due to the 
pandemic. Moreover, this reduced access was linked to higher psychological distress 
after controlling for pre-pandemic mental health levels (Kidd et al., 2021). Therefore, a 
decrease in social support and additional service disruptions (in particular, mental health 
services) may have a detrimental effect on TGNB people's mental health. 
2.4.3 COVID-19 and interruptions in gender-affirming medical care 
Due to the COVID-19 pandemic, some TGNB persons have been experiencing delays 
and/or reduced access to gender-affirming medical care (Kidd et al., 2021). A study in the 
U.K. reported that the majority of TGNB youth were worried about the COVID-19 
pandemic impact on their transition process as many had difficulties accessing gender-
affirming medical care (Jones et al., 2021). Some of these youths also reported feeling 
social anxiety due to their inability to access gender-affirming medical care; in particular, 
gender-affirming surgical procedures had been cancelled with no new rescheduled date 
(Jones at al., 2021). A predominantly European, cross-sectional study of TGNB adults 
revealed that among those who received or were planning to receive gender-affirming 
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care, approximately 60% were concerned that future transgender health care would be 
difficult to access due to the ongoing pandemic (Koehler et al., 2020). Moreover, about 
half of the respondents who had already received some type of gender-affirming care had 
experienced difficulties in accessing transgender healthcare services due to the pandemic. 
For example, 21.8% reported that their access to hormones was currently restricted, with 
another 15.6% and 19.5% reporting that their surgery was cancelled/postponed or that 
they expect that it will be cancelled/postponed, respectively (Koehler et al., 2020). A U.S. 
study also reported that 11.1% of TGNB participants in their study experienced a surgery 
cancellation and 32.7% reported an interruption in hormonal care (Kidd et al., 2021). A 
cross-sectional, global study of TGNB adults (n=849) determined that among the 
participants who were receiving gender-affirming care prior to the pandemic, 33.2% and 
31.1% experienced a reduction in hormone treatments and surgical after-care, 
respectively (Restar et al., 2021). This same study also found that interruptions in gender-
affirming care partially mediated the relationship between the impact of socioeconomic 
loss and poor mental health outcomes during the pandemic. 
2.4.4 Interruptions in gender-affirming medical care and mental 
health 
Before data had become available, commentaries and opinion pieces had expressed 
concerns about the potential negative effects of delays in gender-affirming care due to 
COVID-19 on TGNB mental health (Herman & O’Neill, 2020; Wang et al., 2020; van 
der Miesen et al., 2020; Pearce et al., 2020). Due to the postponement of in-person 
consultations and surgeries, TGNB persons could have difficulties in accessing hormone 
therapy and/or gender-affirming surgeries (Wang et al., 2020), wherein a lack of access to 
this care could result in increased suicidal ideation and attempts (Herman & O’Neill, 
2020). Moreover, TGNB persons often have already overcome many barriers to schedule 
their surgical procedures, including financial, legal and geographic obstacles (Roberts et 
al., 2020). For example, in Germany, just the application process for top surgeries can 
take anywhere from two to six months (Eickers, 2020). There are also limited surgeons 
who specialize in these procedures which increases wait-times and can affect the mental 
health of this population.   
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Currently, there are a few studies that have investigated the association between delays in 
gender-affirming medical care and mental health (Zwickl et al., 2021; Jarrett et al., 2021; 
Kidd et al., 2021). A cross-sectional study of TGNB persons in Australia showed that 
those who experienced cancellations in gender-affirming surgeries were more likely to 
have thoughts of self-harm or suicide (Zwickl et al., 2021). A global, cross-sectional 
study discovered a relationship between screening positive for depression and anxiety 
and reduced access to gender-affirming resources (e.g., hormone therapy, surgery after-
care, mental health services, cosmetic supplies, body modifiers) due to the COVID-19 
pandemic (Jarrett et al., 2021). When examining the relationship between gender-
affirming care and suicidal ideation, the authors found a similar trend—among the 
individuals who had rare or no suicidal ideation during the onset of the pandemic, those 
who had experienced a loss of access to at least one gender-affirming resource reported 
greater suicidal ideation (Jarrett et al., 2021). In contrast, a U.S. longitudinal cohort study 
of TGNB individuals aged 16 or older did not find a significant relationship between 
interruptions in gender-affirming care and greater psychological distress (Kidd et al., 
2021). Initially, while controlling for gender identity and age, interruptions in gender-
affirming care due to the pandemic was associated with greater psychological distress. 
However, after the investigators adjusted for pre-pandemic mental health, this 
relationship was no longer significant (Kidd et al., 2021). 
2.5 Potential implications of COVID-19 disruptions on 
TGNB people and their mental health 
With the potential of disruptions in hormonal prescriptions amidst the pandemic, an 
increasing number of TGNB persons may search for alternative methods to acquire 
hormones in order to prevent unwanted changes to secondary sex characteristics. Online 
forums are frequently being used in the TGNB community for individuals seeking advice 
for obtaining hormones as they begin to run short on supply (Edenfield, 2021). It is 
important to note that online forums may provide advice that are not written by 
physicians with medical expertise. Therefore, the medical advice provided could lead to 
an increasing number of individuals exhibiting risky behaviours to acquire hormones, 
which could be very dangerous and detrimental to their health. Van der Miesen et al. 
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(2020) concluded that there will likely be an even greater delay for individuals seeking 
gender-affirming care in the future due to the reduced capacity of healthcare systems and 
cancellations of previous procedures. Given the relationship between gender-affirming 
care and mental health, this may result in heightened mental health complications in the 
TGNB population.  
Not only can the pandemic impact gender-affirming care, but it can also contribute to an 
increased difficulty in accessing needed health care among this population. Prior to the 
pandemic, TGNB persons were already experiencing barriers when seeking health care, 
including a deficiency of knowledgeable healthcare professionals in transgender health 
and long wait times to see transgender-friendly providers (Wang et al., 2020; Carman et 
al., 2020). This may be even more exacerbated due to social distancing measures 
(Carman et al., 2020). Moreover, some TGNB persons have previously encountered 
discrimination or discomfort when seeking care which may explain why some delay 
seeking care or experience a lower quality of care (Pearce et al., 2020; Herman and 
O’Neill, 2020). Delayed care and treatment results in a greater risk of developing serious 
and life-threatening consequences of COVID-19. Additionally, TGNB persons may have 
appointments with psychiatrists and/or therapists postponed or moved to an online format 
(Eickers, 2020). This could lead to a decreased frequency and/or lower standards of 
available mental health services for TGNB persons, especially if there is a lack of quality 
in the telehealth being offered (van der Miesen et al., 2020). Given that TGNB persons 
were already experiencing a greater level of mental health complications than the general 
population, these difficulties in accessing needed health care can be detrimental to their 
mental well-being.  
The closure of businesses, office spaces and schools has resulted in an increased number 
of individuals working and studying from home, including TGNB persons. The ability to 
work from home has resulted in positive experiences for some TGNB individuals, while 
others have experienced increased distress due to this change in environment. Some 
TGNB persons might enjoy working from home because they are able to use their 
bathroom at home, rather than having to decide whether they can use the bathroom that 
reflects their gender identity at their current workplace (Konnoth, 2020). In contrast, 
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some may have negative experiences working from home. For example, since in-person 
conversations can no longer take place, phone calls may be used more frequently to 
communicate. As a result, TGNB persons may get misgendered on telephone calls 
because the individual on the other line can only listen to their voice and cannot see their 
physical appearance (Konnoth, 2020).  
School closures can also have a negative impact on TGNB youth who must go home to 
families that are unsupportive of their gender. This is especially harmful for youth who 
have peer support at school and frequently use the mental health programs offered 
(Salerno et al., 2020).  Additionally, some businesses have opted to completely close due 
to the economic strain caused by the pandemic, resulting in job losses and an increase in 
unemployment. The 2015 U.S. Transgender Survey revealed that the unemployment rate 
for transgender persons was already three times higher compared to the general U.S. 
population (James et al., 2016). Transgender respondents were also more likely to live in 
poverty compared to the U.S. population (29% vs. 12%). Given that lower socioeconomic 
status has been previously associated with a higher prevalence of health risks (Stronks et 
al., 1998), TGNB persons may be at a greater risk of both the short and long-term 
implications of the COVID-19 pandemic. Aside from unemployment and income 
affecting both financial stability and physical health, it also may result in increased 
mental health issues for TGNB persons who rely on employment insurance to cover their 
gender-affirming medical care (van der Miesen et al., 2020).   
Stay-at-home orders and social isolation may be detrimental for TGNB individuals, 
specifically for those who have unsupportive families or are at a greater risk for partner 
violence (Herman & O’Neill, 2020). One study discusses how social distancing can have 
negative implications on the mental health of SGM populations (Phillips et al., 2020). For 
example, factors contributing to minority stress can become more prevalent during the 
pandemic, including poor social support. A supportive network can include people 
outside of one’s household, such as friends, teachers, co-workers, and community groups 
and organizations. With the ongoing pandemic, TGNB persons may be experiencing even 
greater levels of social exclusion due to separation from supportive individuals who are 
not living in their household and reduced availability of safe spaces (Carman et al., 2020; 
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van der Miesen et al., 2020). It is important to note that TGNB persons may not solely 
rely on medical professionals for mental health services; local community centres and 
organizations can also provide mental health support for these individuals (Eickers, 
2020). However, many of these organizations were not able to operate due to COVID-19 
measures. Therefore, this can result in a decrease in social support and acceptance for 
TGNB persons who do not have a solid support system at home. Eickers (2020) also 
noted that social isolation, which may result from a combination of both difficulties 
accessing TGNB specific health care and reduced social support, can have a negative 
impact on the mental well-being of transgender individuals; especially for those who 
were already suffering from mental health complications pre-pandemic.  
Furthermore, social distancing guidelines can have an indirect effect on substance abuse 
as individuals may turn to alcohol and/or drugs as a coping strategy since there are less 
supportive resources available during these unprecedented times (Carman et al., 2020). 
There is some evidence to suggest that alcohol and drug abuse is more prevalent in 
LGBTQ+ populations compared to the broader population (Ritter et al., 2012; Roxburgh 
et al., 2016). In particular, substance abuse among transgender persons has been 
previously linked to increased stigma and social exclusion (Scheim et al., 2017). A 
Canadian study reported that approximately 12% of the transgender population in Ontario 
used at least one high-risk drug in the past year, in which transgender persons were also 
more likely to use both cocaine and amphetamine compared to the non-transgender 
population (Scheim et al., 2017).  Given that social exclusion has previously been linked 
to drug use, this could potentially result in increased substance abuse during the 
pandemic and additional physical and mental health complications for this population.  
Overall, there is very limited research that has examined the relationship between 
interruptions in gender-affirming care due to COVID-19 and mental health. The majority 
of the existing literature consists of cross-sectional studies and opinion pieces which 
make it impossible to determine causation. Moreover, a recent longitudinal study 
reported contradicting results with regards to this association when compared to the other 
cross-sectional studies, demonstrating a further need to assess this relationship with 
longitudinal data. Many of these studies were also conducted outside of Canada which 
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reduces the generalizability to the Canadian population. Importantly, some researchers 
who have investigated this relationship have called for future research with longitudinal 
data to better understand the relationship between interruptions in gender-affirming care 
due to COVID-19 and mental health (Restar et al., 2021). Given the limited longitudinal 
research that is available and the lack of research that has included the TGNB Canadian 
population, this current study has the unique opportunity to longitudinally examine the 
impact of interruptions in gender-affirming care due to COVID-19 on anxiety and 
depression among TGNB people in Canada. 
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Chapter 3  
3 Methods 
This chapter will provide an overview of the study sample, the variables included in the 
analysis and how they were measured, along with statistical analyses that were 
performed. 
3.1 Study sample 
Trans PULSE Canada was a national community-based survey funded by the Canadian 
Institutes of Health Research (CIHR) that focused on the health and well-being of 
transgender and non-binary people in Canada. In particular, the Trans PULSE Canada 
study seeks to describe and compare health outcomes and access to healthcare among 
transgender and non-binary people across different provinces/territories, as well as 
gathering additional information on nine priority population groups (individuals with 
disabilities, Indigenous persons, sex workers, non-binary individuals, racialized persons, 
those living in a rural location, immigrants and newcomers, youth and older adults). To 
be eligible to participate, individuals had to be over the age of 14, reside in Canada, and 
identify as a gender other than what they were assigned at birth. To recruit participants in 
the study, the majority of the promotion took place through social media (e.g., Trans 
PULSE Canada website, Facebook, Twitter) and community organizations. There were 
also eleven peer research associates (PRA) hired across Canada who promoted the 
questionnaire locally and were available to collect data in person via tablets.  
The Trans PULSE Canada study was originally designed as a multi-mode national cross-
sectional survey. However, given the situation with COVID-19 in 2020, the research 
team decided to create a new COVID-19 related survey which would capture how the 
pandemic had impacted the lives of TGNB persons in Canada—this new study was called 
the Trans PULSE COVID Cohort. As a result, this thesis is a longitudinal study using 
both the 2019 and 2020 datasets. To be eligible to participate in the 2020 survey, 
individuals had to have participated in the Trans PULSE Canada survey in 2019 and they 
had to be currently living in Canada. To recruit participants, an invitation was sent to 
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those individuals who had provided contact information and consent for recontact in the 
2019 survey. Each participant was recontacted via phone, email or mail depending on the 
information provided on the previous survey.  
For the Trans PULSE Canada survey in 2019, data were collected for ten weeks in the 
summer of 2019. Participants could complete the questionnaire online, in paper or over 
the phone in either English or French. There was also the option to complete the 
questionnaire via phone with a language interpreter. Two versions were available for 
participants—a longer questionnaire and a short form. The full-length questionnaire 
focused on many aspects of health and well-being, including questions on gender-
affirming care, experiences with health services, physical and mental health status, social 
support, gender positivity and distress, and identity documents. Participants were able to 
save and exit the online questionnaire at any time if they were unable to complete it in 
one sitting, as well as schedule multiple sessions if the questionnaire was being 
completed via phone or in-person with a PRA. The short-form questionnaire was 
available to those who were unable or were not willing to complete the longer version of 
the questionnaire and it included questions on demographics, along with one key question 
from each major section in the full-length questionnaire. At the end of the questionnaire, 
participants were given the opportunity to provide contact information if they were 
willing to be recontacted for potential future studies. However, this was not a requirement 
to participate in the study. For those who provided contact information, the contact 
information and questionnaire answers were stored separately. Additionally, there was no 
honorarium for completion of the questionnaire.    
All data were stored on REDCap servers at Western University. REDCap is a highly 
secured web application used for surveys and databases. Research Ethics Board (REB) 
study approval was obtained from the Unity Health Toronto Research Ethics Board at St. 
Michael’s Hospital, the Human Research Ethics Board at University of Victoria, Non-
Medical Research Ethics Board at Western University, and the Research Ethics Board of 
Wilfrid Laurier University. Given that youth were also able to participate in the study, it 
is important to note that parental/guardian consent was waived for youth under the age of 
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18 in order to protect the safety of transgender and non-binary youth who may have not 
disclosed their gender identity to their parents or others.  
For the Trans PULSE COVID Cohort, data were collected for approximately four weeks 
in the fall of 2020. Eligible participants were able to complete the questionnaire online or 
in paper format. If there were any issues with accessing the questionnaire due to 
communication difficulties (e.g., if they had used translators for the 2019 questionnaire), 
those individuals were directed to contact the project coordinator or principal 
investigators who would aid in providing appropriate accessibility. The Trans PULSE 
COVID questionnaire included sections on sociodemographics, healthcare access 
(primary, emergency, gender-affirming care etc.), physical and mental health status, 
COVID-19 testing and care, as well as access to community and social support. Some 
questions used standardized study instruments, while others were adapted from the 
TransCare COVID-19 questionnaire and Statistics Canada population questionnaires. 
Participants were able to pause the online and paper questionnaires and restart at a later 
time if needed. At the end of the questionnaire, they were also able to update the contact 
information that was provided in the 2019 questionnaire. A $20 gift card honorarium was 
given to participants upon completion (President’s Choice, Amazon.ca, Tim Horton’s or 
Indigo).  
All data were securely stored on REDCap servers at Western University and REB study 
approval was obtained from the Institutional Review Board at Drexel University, the 
Non-Medical Research Ethics Board at Western University, the Human Research Ethics 
Board at University of Victoria and the Research Ethics Board at Wilfrid Laurier 
University. Lastly, in contrast to the sharing protocol for the Trans PULSE Canada data 
which only allowed de-identified data to be accessible to the team’s Data Analysis 
Working Group, anonymized data from the COVID cohort will be made available to the 
public.   
There were a total of 3524 questionnaires completed in 2019. Observations were deleted 
if they were (1) identified as non-participants (e.g., team members entering the online 
questionnaire for testing), (2) those who logged in but did not start the questionnaire, (3) 
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bots and trolls or (4) duplicate entries. As a result, the following observations were 
deleted: 8 questionnaires as they were non-participant entries, 527 due to incompletion of 
multiple key early demographic questions (age, ethnoracial identity, person of colour, 
immigration, sex assigned at birth, gender identity category), 2 due to trolls and 114 were 
duplicate entries. This resulted in a final sample size of 2873 in 2019. Of the total 2873 
final study participants, there were 2870 that were completed online or in paper, 0 by 
telephone, and 3 were administered by PRAs (all in English). Of the participants who 
completed the questionnaire in 2019, there were 1184 who had provided consent for 
recontact however, the contact information was invalid for some individuals. Therefore, 
of those who had valid information and were contacted for the Trans PULSE COVID 
Cohort, there were a total of 826 survey respondents. Observations were removed if 
consent was not provided on the questionnaire. All questionnaires were completed online. 
This resulted in a final sample size of 820 for the 2020 data collection period.  
This thesis is a longitudinal study using both the 2019 pre-pandemic and 2020 pandemic 
datasets in order to assess the impact of interruptions in gender-affirming care during 
COVID-19 on changes in anxiety and depression among Trans PULSE Canada 
participants. Individuals were included in the study if (1) they completed both the 2019 
full questionnaire and 2020 COVID questionnaire, (2) at the time of the 2019 survey, 
were aged 14 or older, lived in Canada and identified as a gender other than what they 
were assigned at birth (general criteria from the 2019 survey), and (3) at the time of the 
2019 survey, they either had completed, were in process, or were planning to receive 
gender-affirming care. Those who were not planning to receive gender-affirming medical 
treatment or were not sure whether they would seek gender-affirming medical treatment 
in 2019 were excluded. As a result, there were 611 survey respondents included in the 
final analytic sample for this study. 
3.2 Directed acyclic graphs 
Directed acyclic graphs (DAGs) offer a visual representation of the causal relationships 
between dependent and independent variables while also providing the association of 
these variables with other covariates. In particular, DAGs can be used to determine 
whether other covariates might confound the relationship between the exposure and 
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outcome. A variable is a confounder if it has the ability to distort the true relationship 
between an independent and dependent variable by playing a causal role in the outcome 
of interest and having an association with the exposure. By using DAGs, one can 
determine minimally sufficient adjustment sets— the minimum set of confounder 
variables one needs to adjust for to measure a causal relationship without the risk of 
confounding bias (Foraita et al., 2014).   
For some research questions, the construction of a DAG can become very complex; this 
in turn has resulted in the production of the online web application known as DAGitty 
(Textor et al., 2016). This application allows the user to easily draw DAGs to determine 
minimum sufficient adjustment sets for their research question of interest. To determine 
what variables might be relevant to include in the DAG, one can use previous research 
found in the literature, a priori knowledge, along with other information such as theories 
or expert opinions (Foraita et al., 2014). For this thesis, DAGitty was used to determine a 
minimum sufficient set of confounders to adjust for in order to measure an unbiased 
association between interruptions in gender-affirming care and the outcomes, anxiety and 
depression (Figure 1). For our DAG, we decided to include both outcomes, anxiety and 
depression, in order to determine a common minimum sufficient adjustment set that 
could work for both models. Previous literature was used to determine other risk factors 
that may play a causal role in anxiety and depression. Given the limited research 
available on this topic, a priori knowledge was also used to determine relevant variables 
to include in the DAG. Both measured and unmeasured variables that were relevant in 
assessing the relationship between interruptions in care and anxiety and depression were 
included in the DAG by the user. DAGitty also allows users to force adjustment for 
specific covariates that they would like to be included in every adjustment set (Textor, 
2011). For this thesis, the specific covariates that we wanted to include (pre-pandemic 
anxiety and depression) were already included in the eight possible minimal sufficient 
adjustment sets that DAGitty had created; therefore, we did not need to force adjustment. 
To select our final adjustment set from the eight options that DAGitty provided, we 
prioritized a set that did not include unmeasured variables, had a smaller number of 
covariates to adjust for and variables with minimal missing data (Austin et al., 2019). As 
a result, the minimum sufficient adjustment set included the following variables: change 
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in income due to COVID-19, current geographic location (province/territory), current 
social support, educational attainment, fear of COVID-19 (COVID-19 related health 
concerns), household poverty past year (low-income household), pre-pandemic anxiety 
and depression and pre-pandemic gender-affirming care status (2019). 
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Figure 1  
Directed acyclic graph (DAG) of the relationship between interruptions in gender-
affirming care and anxiety and depression 
 
Legend 
   Exposure                    Ancestor of the exposure and outcome variables               
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3.3 Study measures 
3.3.1 Exposure variables 
Interruptions in gender-affirming care. Three variables from the Trans PULSE 
COVID Cohort questionnaire were used to create a composite variable on interruptions in 
gender-affirming care. The first focused on interruptions in taking hormones: “Since 
March 12, 2020, have you had interruptions in taking hormones?”. The potential response 
options were “Yes” or “No”. This question was only asked to those participants who take 
hormones. The second focused on inability to get a new prescription for hormones: 
“Since March 12, 2020, have you been unable to get a new prescription or referral for 
hormones?”. There were three response options: “Yes,” “No,” and “I haven’t needed this 
during this time”. Both of these items were developed by the Trans PULSE Canada 
Team. The final variable focused on surgery interruptions: “Have you had a surgery 
appointment canceled or postponed due to the current COVID-19 outbreak?”. Possible 
responses were “Yes,” “No,” and “Not yet, but I expect it will”. This was only asked to 
participants who had a gender-affirming surgery booked before March 12, 2020. This 
questionnaire item was adapted from the TransCare COVID-19 project (TransCare 
Hamburg, 2020) — an international, online survey that focused on how transgender 
persons have been affected by COVID-19 in terms of physical health, mental health and 
transgender health care.  
For the composite variable, participants were categorized into four groups: (1) 
interruptions in taking hormones, (2) surgical interruptions, (3) interruptions in taking 
hormones and surgical interruptions, and (4) no interruptions in gender-affirming care. 
Those who had interruptions in taking hormones and those who were unable to get a new 
prescription or referral for hormones were grouped together as having “interruptions in 
taking hormones”. Those who answered “Yes” or “No” to the items were categorized into 
the appropriate interruption group. Additionally, those who had responded “Not yet, but I 
expect it will” for surgical interruptions or “I haven’t needed this during this time” for 




3.3.2 Outcome variables 
Anxiety. The Overall Anxiety Severity and Impairment Scale (OASIS) was used to 
measure self-reported pandemic anxiety levels. Developed by Norman et al. (2006), the 
OASIS is a continuous measure that can be used to measure the severity of any anxiety 
disorder, assess the severity and impairment across multiple anxiety disorders, as well as 
capture subthreshold anxiety symptoms. It was designed to be a very brief questionnaire 
so that it could be used in many different settings, ranging from a primary care 
environment to population-based research studies (Campbell-Sills et al., 2009). OASIS is 
a five-item scale that consists of the following questions: (1) In the past week, how often 
have you felt anxious?, (2) In the past week, when you have felt anxious, how intense or 
severe was your anxiety?, (3) In the past week, how often did you avoid situations, 
places, objects, or activities because of anxiety or fear?, (4) In the past week, how much 
did your anxiety interfere with your ability to do the things you needed to do at work, at 
school, or at home?, (5) In the past week, how much has anxiety interfered with your 
social life and relationships? To answer these questions, respondents are asked to 
consider all of their experiences (e.g., panic attacks, situational anxieties, worries) and 
include all of their anxiety symptoms. For each item, a 5-point Likert-type scale is used 
with the scores ranging from 0-4; the scores for each item are added to represent a total 
score (ranges from 0-20). A higher score indicates greater anxiety severity and 
impairment, with a cut-point of eight or higher indicating a probable anxiety disorder. 
OASIS is a validated measure used in many different populations and settings, ranging 
from a non-clinical sample of college students to diverse clinical samples in the U.S. and 
other multicultural populations (Campbell-Sills et al., 2009; Norman et al., 2006; 
Hermans et al., 2015).  
Depression. The 10-item Centre for Epidemiological Studies Depression Scale (CES-D-
10) was used to measure self-reported pandemic depression levels. The original CES-D 
consists of 20 items and has been widely used to identify both clinical and non-clinical 
depressive symptoms in diverse populations (Radloff, 1977; Shinar et al., 1986). 
However, due to the length of the 20-item scale, both clinicians and survey researchers 
are sometimes reluctant to use the full-length scale. A shorter version of the original 
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CES-D scale was derived in which 10 of the 20 items are used to assess depressive 
symptomology in the past week (Andresen et al., 1994). In order to shorten the scale, 
items that did not have high correlations to the total score or items that were highly 
correlated with each other and therefore repetitive were removed (Andresen et al., 1994). 
As a result, there are three items on depressed mood, five items on somatic symptoms, 
and two on positive mood (Baron et al., 2017). The CES-D-10 uses a 4-point Likert-type 
scale where items are scored from 0-3, wherein 0 is “Rarely or none of the time” and 3 is 
“Most or all of the time”. The score is reversed for 2 items (5 and 8) which represent 
positive mood. A final score is determined by totaling the scores of each item; the 
possible range for the final score is 0-30. A higher score represents greater depressive 
symptoms, with a cut-point of ten or higher indicating depressive symptoms consistent 
with clinical depression (Andresen et al., 1994). The CES-D-10 has proven to have strong 
psychometric properties, demonstrating good reliability in community samples and 
varying populations, including older adults and adolescents (Irwin et al., 1999; Cheung et 
al., 2007; Bradley et al., 2010). 
3.3.3 Descriptive characteristics 
Age. In the questionnaire, participants were asked how old they were in years. For this 
thesis, age was coded into six categories: “14-19”, “20-24”, “25-34”, “35-49”, “50-64”, 
“65+”, as well as 3 categories: “14-24”, “25-49”, and “50+” for descriptive analyses. The 
three-group age variable was created as it includes two meaningful Trans PULSE Canada 
priority populations—youth and older adults.  
Gender. Participants were asked about their current gender identity with the following 
response options: “Man or boy”, Woman or girl”, “Indigenous or other cultural gender 
identity (e.g., two-spirit)” or “Non-binary, genderqueer, agender, or a similar identity.”   




Province/territory. Participants were asked what province or territory they currently 
lived in. For this thesis, the three territories were grouped together for analyses due to 
small sample sizes. 
Indigenous status. A binary variable for Indigenous status was created. All participants 
were asked about their ethnoracial background. Those who selected “Indigenous” were 
asked a follow-up question on which group they belonged too. Responses that included 
“First Nations (status)”, “First Nations (non-status)”, “Métis”, “Inuk”, or “Indigenous 
from Canada, don’t know which group” were categorized as “Indigenous”. Participants 
who did not select “Indigenous”, or who responded “Indigenous from another country” or 
“Unsure” to the follow-up question, were categorized as “Not Indigenous”. 
Racialization. A binary variable for racialization was created using two items from the 
questionnaire: “Are you perceived or treated as a person of colour in Canada?” and “Do 
you identify as a person of colour?”. Response options for these variables were “Yes” or 
“No”. Individuals were coded as “Racialized” if they responded yes to one or both of 
these items and “Not Racialized” if they did not.  
Immigration history. In the questionnaire, participants were asked “What country were 
you born in?”. Possible response options were “Canada”, “Outside of Canada” or 
“Unsure”. A binary variable was created to represent immigration history, in which those 
who were born outside of Canada were classified as being an “Immigrant”. 
Urban/rural. There were two questions in the questionnaire pertaining to postal code. 
The first asked participants for their postal code for where they live or get mail. For those 
who did not want to share their full postal code, there was also an option to share just the 
first three digits. Both postal code questions required a write-in response. To code a 
binary variable for living in a rural area, Community Size was used to determine rurality. 
Community Size was derived from the census metropolitan area/census agglomeration 
designation. Postal Code Conversion File Plus (PCCF+) version 7B was used to assign 
the postal codes to communities’/census areas (Statistics Canada, 2018). Those living 
outside of census metropolitan areas and census agglomerations were coded as living in a 
rural area or small town (less than 10 000 people).  
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Education. Survey respondents were asked about the highest level of formal education 
that they have completed. There were 13 response options, ranging from “Some 
highschool, no diploma or GED” to “Doctoral or professional degree”. For this thesis, 
responses were coded into five groups: “<Highschool”, “High school diploma”, “Some 
college or university or CEGEP”, “College or university degree, or CEGEP degree, 
including those with some grad school, no degree”, or “Grad/professional degree, 
including those who reported some Doctoral/professional work, no degree”.  
Income. Participants were asked about their total personal income, before taxes and other 
deductions from all sources in 2019. There were 13 response options, ranging from “Less 
than $10,000” to “$150,000 or more”. There were also response options for those who 
did not have or were unsure of their personal income. For the purposes of this thesis, 
personal income was grouped into the following categories: “No personal annual 
income”, “<$15,000”, “$15,000-$29,999”, “$30,000-$49,999”, “$50,000-$79,999”, or 
“$80,000+”. 
3.3.4 Confounder variables – minimum sufficient set 
Income changes due to COVID-19. The questionnaire asked respondents aged 16 or 
older “How much of an impact did the COVID-19 pandemic have on your personal 
income from employment?”. The response options included “Major negative impact”, 
“Moderate negative impact”, “Minor negative impact”, “No impact”, “Minor positive 
impact”, “Moderate positive impact”, “Major positive impact”, or “Too soon to tell”. For 
this thesis, responses were coded into three groups: “Positive impact”, “Negative impact” 
or “No impact/too soon to tell”. This item was adapted from Statistics Canada (Statistics 
Canada, n.d.).  
Current social support. To measure available social support, the eight-item modified 
Medical Outcomes Study Social Support Survey (mMOS-SS) was used (Moser et al., 
2012). Participants were asked "How often is each of the following kinds of support 
available to you right now?”. There were 8 items included in the mMOS-SS survey such 
as, “Someone to help you if you were confined to bed”, “Someone to take you to the 
doctor if you needed it”, “Someone to have a good time with” etc. For each item, a 5-
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point Likert-type scale is used with the scores ranging from 1-5 where 1= “None of the 
time”, 2= “A little of the time”, 3= “Some of the time”, 4= “Most of the time”, and 5= 
“All of the time”. The final social support score is determined by computing the average 
of the scores for all eight items included. A higher score indicates more support 
(Sherbourne & Stewart, 1991).   
COVID-19 related health concerns. Participants were asked about their concerns 
during the COVID-19 pandemic in regard to their own health, “How concerned are you 
about each of the following impacts of COVID-19? …  My own health”. The response 
options were “Not at all”, “Somewhat”, “Very” or “Extremely”. This measure was 
adapted from Statistics Canada (Statistics Canada, n.d.). 
Low-income household. This measure was derived according to Statistics Canada’s 
Low-Income Measure (Statistics Canada, 2021a) using two questions from the 
questionnaire pertaining to total income from all members living in the household and the 
number of people supported on the household income. The Statistics Canada Low-
Income Measure (LIM) determines low-income households and adjusts household 
income by the number of people supported on the income. As such, there are different 
LIM thresholds for different household sizes. Therefore, the LIM compares all the 
participants’ incomes to the average person’s income while adjusting for household size; 
those who had fallen below the LIM thresholds were coded as “Low-income household” 
and those who did not were coded as “Not in a low-income household”.  
Pre-pandemic anxiety and depression. Pre-pandemic depression and anxiety measures 
were coded the same way as the anxiety and depression outcome measures using data 
from the 2019 questionnaire.  
Pre-pandemic gender-affirming care status (2019). Participants were asked “Which of 
the following applies to your current situation regarding puberty blockers, hormones, 
and/or surgery?” with the following response options, (1) I have had the gender-affirming 
medical treatment I need/want, (2) I am in the process of completing gender-affirming 
medical treatment, (3) I am planning to receive gender-affirming medical treatment, but 
have not begun, (4) I am not planning to receive gender-affirming medical treatment, or 
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(5) I am not sure whether I am going to seek gender-affirming medical treatment. For this 
thesis, those who were not planning or not sure whether they would seek gender-
affirming medical treatment were excluded. 
3.3.5 Descriptive variables pertaining to gender-affirming care 
Most items in the questionnaire that were used to describe gender-affirming care were 
developed by the Trans PULSE Canada Team, unless otherwise stated.  
Gender-affirming care status in 2020. The same item used to measure pre-pandemic 
gender-affirming care status in 2019 was used to measure gender-affirming care status in 
2020.  
Take hormones. Respondents who said they have had or were in the process of 
completing gender-affirming medical treatment were asked if they take hormones 
(yes/no).  
Current access to hormones. For those who said they take hormones, they were also 
asked if they currently have access to hormones (yes/no).  
Interruptions in taking hormones. Participants who said they take hormones were 
asked whether they had interruptions in taking hormones since March 12, 2020 (yes/no).  
Reasons for inability to access hormones. This item was asked to participants who said 
they had interruptions in taking hormones. Response options included “Couldn’t afford 
it”, “Couldn’t go to the pharmacy”, “Couldn’t get my prescription renewed”, “Couldn’t 
get syringes or needles”, “Drug shortages”, “Nobody to help with injections”, “People in 
my household couldn’t know I’m taking hormones”, and “Other”.  
Unable to get new prescription for hormones. Those who were planning or in the 
process to receive gender-affirming medical treatment were asked if they were unable to 
get a new prescription or referral for hormones since March 12, 2020. Responses 
included “Yes”, “No”, and “I haven’t needed this during this time”.  
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Unable to get new prescription for hormones because of COVID-19 restrictions. For 
those who were unable to get a new prescription or referral for hormones, they were 
asked whether this was because of restrictions related to COVID-19 (yes/no).  
Booked appointment for gender-affirming surgery. Those who were planning or in the 
process to receive gender-affirming medical treatment were asked if they had an 
appointment booked to have a gender-affirming surgery in the future before March 12, 
2020 (yes/no).  
Surgery appointment canceled due to COVID-19. Those who had a surgery booked 
were asked whether they had a surgery appointment canceled or postponed due to the 
current COVID-19 outbreak. Responses included “Yes”, “No” and “Not yet, but I expect 
it will”. This questionnaire item was adapted from the TransCare COVID-19 project 
(TransCare Hamburg, 2020). 
Alternate date set for surgery. For participants who experienced surgery cancellations, 
they were asked whether an alternative date was set for the surgery (yes/no). This 
questionnaire item was adapted from the TransCare COVID-19 project (TransCare 
Hamburg, 2020). 
Type of surgery cancelled. For those who had a surgery appointment cancelled, they 
were asked what type of surgery was cancelled or postponed. Response options included 
“Chest surgery”, “Genital gender-affirming surgery”, “Removal of uterus (hysterectomy) 
or removal of ovaries (oophorectomy)”, “Voice surgery”, “Adam’s apple surgery”, 
“Facial surgery”, and “Other surgery”. This questionnaire item was adapted from the 
TransCare COVID-19 project (TransCare Hamburg, 2020). 
Had this surgery. Participants who had a surgery appointment canceled or postponed 
due to COVID-19 were asked whether they had this surgery yet (yes/no).  
Limited access to gender-affirming health care. All respondents were asked whether 
the COVID-19 outbreak limited their access to the following aspects of gender-affirming 
health care: (1) Binders, packers, or gaffs, (2) Non-medical supplies, (3) Medical material 
that is important after surgery, and (4) Post-operative care following gender-affirming 
41 
 
surgery. Response options included “Yes”, “No” and “Not applicable”. This item was 
adapted from the TransCare COVID-19 project (TransCare Hamburg, 2020). 
3.4 Data considerations 
3.4.1 Sample merging and weights 
The 2019 and 2020 datasets were merged into one working dataset before conducting any 
analyses. Participants who had not completed the 2020 COVID questionnaire were 
removed. For this thesis, weights were applied to all descriptive and regression analyses 
to ensure that the 2020 survey data would represent the sample from the 2019 survey. 
Sampling weights were provided by the Trans PULSE Canada team. Variables that were 
included in the weights were chosen by looking at the differences in the distribution 
between survey respondents who completed the full length 2019 questionnaire and the 
2020 questionnaire. The sample weights for the population ranged from 0.40 to 2.50. 
Overall, the weighted analyses were used to mitigate biases related to 2019 survey 
completion, consent for re-contact, reachability and COVID-19 survey participation.  
3.4.2 Missing data 
536 of 611 survey respondents had complete data for all variables while 75 (12.3%) were 
missing data for one or more variables. There were no missing data for interruptions in 
gender-affirming care, anxiety and depression at time point 2, province/territory of 
residence, educational attainment, social support and gender-affirming care status in 
2019. However, other covariates that were included in the regression analyses were 
missing. By looking at Table 1, we can see that the percentage of missingness for each 
individual variable was relatively low. The categorical/binary variables that had missing 
data included COVID-19 related health concerns with 0.16% missing, income changes 
due to COVID-19 with 1.15% missing and the low-income household measure with 
6.87% missing. Two continuous covariates, pre-pandemic anxiety and depression, both 




Missingness for the confounder variables 
Variable Missing observations (n) Percent Missingness (%)* 
COVID-19 related health concerns 1 0.16% 
Income changes due to COVID-19 7 1.15% 
Low-income household 42 6.87% 
Pre-pandemic anxiety 36 5.89% 
Pre-pandemic depression  36 5.89% 
*Note: This was calculated using a denominator value of 611 which is the analytic sample for this thesis.  
Bennett (2001) suggested that when the proportion of missing data is greater than 10%, 
statistical analyses have the potential to become biased. In this thesis, missingness was 
below 10% for all variables, however given that there were missing data for a few 
different variables, a concerning proportion of the sample would be excluded if a 
complete case analysis was performed for the regression analyses. It was decided that the 
loss of 75 observations might be substantial in terms of impacts on power and precision 
(Sterne et al., 2009). Therefore, multiple imputation was used in the regression analyses.  
Multiple imputation is commonly used due to its robustness and practicality in dealing 
with missing data (Berglund & Heeringa, 2014). It has been adapted for use in many 
commonly used statistical packages, including SAS. Multiple imputation uses the 
distribution of observed data from other variables to estimate multiple values that are 
plausible for the missing data (White et al., 2011). There are different methods to 
multiply impute missing data in SAS. To determine the optimal method for this thesis, we 
considered the pattern and type of data we were working with. Upon examination of the 
missing data pattern, it was determined that there was an arbitrary missing data pattern 
which the Fully Conditional Specification (FCS) and Markov chain Monte Carlo 
(MCMC) methods could accommodate (Berglund & Heeringa, 2014). For this thesis, 
there were missing data for both continuous and classification variables. To use the 
MCMC method with classification variables, a rounding technique must be used to 
impute these variables. This was not recommended because the FCS method has the 
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ability to accommodate mixed variable types without post-imputation rounding. 
Therefore, given the data pattern and types of variables we were using in the analyses, we 
decided the FCS method would be most appropriate (Berglund & Heeringa, 2014).  
The SAS procedure, PROC MI, was used to impute the missing data with the FCS 
method. A random seed value (SEED=1180431796) was assigned and the number of 
imputations were specified in this step. Overall, the recommended number of imputations 
varies in the literature, however a larger number is usually preferred. For low proportions 
of missing data, it has been reported that between 5 and 20 imputations is appropriate 
(UCLA Statistical Consulting Group, n.d.). Therefore, we decided to choose 20 
imputations given that the only burden of choosing the higher number of this range is 
increased computational processing (Berglund & Heeringa, 2014). To impute missing 
data for the select variables, the FCS LOGISTIC command was used for ordinal 
variables, FCS DISCRIM for nominal variables and FCS REGRESSION for continuous 
variables. PROC MIANALYZE was then used to combine the results from the 20 
imputed datasets and to produce valid inferences (Berglund, 2015).  
3.5 Statistical Analysis 
All analyses were performed using SAS software, version 9.4. 
3.5.1 Objectives 1 and 2: descriptive statistics 
To determine the distribution of descriptive statistics and demographics for the entire 
sample, as well as for each of the four interruptions in gender-affirming care subgroups, 
the command PROC SURVEYFREQ was used for all classification variables. The 
WEIGHT statement was also added to compute all frequencies. The SAS survey 
procedures were selected for this thesis due to the complex nature of the survey data. For 
example, the SAS survey procedures allow the user to take into account the complex 
sample design in their analyses which might include stratification, clustering and unequal 
weights (Nadimpalli et al., 2012). For other SAS procedures, including PROC FREQ, the 
inferences made are based on assumptions such as simple random sampling and 
independence of observations. However, when working with survey data with a complex 
sample design, these assumptions may no longer hold. For this thesis, unequal weights 
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were used and it is suggested that SAS survey procedures (e.g., PROC SURVEYFREQ) 
are used when conducting analyses with unequal weights (Vandenbroucke, 2017).  
Additionally, since we were only interested in a subpopulation of the participants, a 
domain analysis was performed for all analyses. According to Lewis (2013), completely 
restricting a dataset to a subpopulation of interest is risky prior to performing SAS 
SURVEY procedures; the use of a BY statement was also cautioned against because both 
can result in incorrect inferences. Lewis (2013) mentions that subsetting the dataset and 
performing a domain analysis will produce differing results for measures of variability 
and degrees of freedom. A domain analysis is an alternative procedure that allows the 
user to analyze a portion of the population that they are interested in while accounting for 
the complex survey data. With a domain analysis, results are produced for the full 
sample, as well as for each subsample that are within the domain variable.  
For this thesis, we decided to perform a sensitivity test to compare the results obtained 
from a domain analysis with the results obtained from subsetting the data. For the 
sensitivity test, we used the PROC SURVEYFREQ procedure and found that both 
methods produced identical weighted frequencies however, the percentages and standard 
errors were not equivalent. Given that we used SAS SURVEY procedures, it was decided 
that performing a domain analysis would be most appropriate for all analyses (Lewis, 
2013). For this thesis, one of the domains represented our analytic sample of interest. The 
excess results produced from the other domain and full population sample were ignored. 
For the descriptive statistics, the domain variable was included in the TABLES statement 
to produce separate results that only included our analytic sample. Lastly, confidence 
intervals were computed for all weighted, descriptive analyses. 
3.5.2 Objective 3: differences in anxiety and depression from pre-
pandemic to pandemic periods  
To address objective 3, pre-pandemic anxiety and depression scores were first subtracted 
from pandemic anxiety and depression scores to obtain a change score. Then, a paired t-
test was used to determine if there was a significant mean difference in anxiety and 
depression scores between the two time points. Specifically, the command PROC 
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SURVEYMEANS was used to determine the mean difference values for the anxiety and 
depression scores. The option “T” was specified to compute the t-values and p-values of 
the two change scores. Weighted estimates were produced by including a WEIGHT 
statement and a DOMAIN statement was also specified to compute separate estimates for 
our subpopulation of interest. Assumptions for a paired t-test were met, including normal 
distribution and independence (between subjects). 
3.5.3 Objective 4: relationship between interruptions in gender-
affirming medical care and pandemic anxiety levels 
Initially, we were interested in analyzing ‘change’ in the two outcome variables. 
However, in the literature, some researchers have raised concerns about using change 
scores as outcomes in regression analyses. Shahar (2009) has argued that using a change 
model does not estimate a causal effect between two time points. The author mentions 
that a change model is actually quite similar to cross-sectional models and that it is only 
superior in terms of having the ability to adjust for time-stable confounders. He also 
demonstrates how subtracting two cross-sectional models yields a change model to 
further emphasize that there is nothing conceptually different between the two (Shahar, 
2009). As a result, it has been cautioned that change scores are simply a derived variable 
and that they are not an effect of interest when exploring causal relationships (Shahar & 
Shahar, 2012). Tennant et al. (2021) also have warned against the use of change scores. 
Since the change score is a combination of two separate events, it merges the associated 
causal pathways and potentially introduces inferential bias in observational studies. For 
this reason, they also suggested using alternative statistical methods. Given the 
conflicting literature on change models, we decided that for this thesis, it would be most 
appropriate to use the follow-up (pandemic) anxiety and depression scores as the 
outcomes in the regression models while adjusting for pre-pandemic anxiety and 
depression levels.   
To examine the relationship between interruptions in gender-affirming care and pandemic 
anxiety, PROC SURVEYREG was used with both DOMAIN and WEIGHT statements. 
Also, the imputed dataset was used for all regression analyses. There were three different 
regression models that were assessed where different covariates and/or interactions were 
46 
 
added to each model. For the first model, we fit a linear regression to look at the 
relationship between interruptions in gender-affirming care and pandemic anxiety, 
adjusting for pre-pandemic anxiety. For the second model, we used multiple linear 
regression to examine the relationship between the exposure and pandemic anxiety, 
adjusting for pre-pandemic anxiety and other potential confounders. In this model, we 
also assessed for an interaction between interruptions in gender-affirming care and pre-
pandemic anxiety levels because we suspected that one’s pre-pandemic anxiety score 
might modify the relationship between interruptions in care and pandemic anxiety (e.g., if 
an individual had a very high or low anxiety score pre-pandemic). If the interaction term 
was not significant (p-value >0.05), it was excluded from the final model. The third 
model used multiple linear regression to examine the relationship between the exposure 
and pandemic anxiety adjusting for pre-pandemic anxiety and other potential confounders 
that were determined from the DAG. This model was reported if the interaction term was 
not significant in the previous model. 
3.5.4 Objective 5: relationship between interruptions in gender-
affirming medical care and pandemic depression levels 
PROC SURVEYREG was used to conduct linear regression analyses for objective 5. A 
domain analysis was performed in order to separately analyze our subpopulation of 
interest and a WEIGHT statement was also included to produce weighted estimates. For 
model 1, a linear regression model was fitted to assess the relationship between 
interruptions in care and pandemic depression, adjusting for pre-pandemic depression. 
For model 2, multiple linear regression was used to determine the association between 
interruptions in care and pandemic depression while adjusting for pre-pandemic 
depression and other potential confounders that were determined from the DAG. An 
interaction term was also added to this model to assess whether pre-pandemic depression 
might alter the relationship between interruptions in gender-affirming care and pandemic 
depression. If the interaction term was significant (p-value <0.05), it was included in the 
final model. The third model used multiple linear regression to examine the relationship 
between the exposure and pandemic depression, adjusting for pre-pandemic depression 
and other potential confounders. If the interaction was significant in the previous model, 
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the main effects model (model 3) was not reported as it would be misspecified. Linear 
regression assumptions were met, including linearity, homoscedasticity and independence 
and normal distribution of residuals. Tolerance values were used to assess for potential 
multicollinearity. No tolerance values were below 0.1, indicating no major concerns 
regarding multicollinearity (O’Brien, 2007). Potential influential data points were also 
examined using Cook’s D which indicated no issues with highly influential outliers. 
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Chapter 4  
4 Results 
This chapter will present the descriptive characteristics of the total sample population as 
well as for each of the interruptions in gender-affirming care groupings. It will also 
describe interruptions in gender-affirming medical care during the COVID-19 pandemic 
and it will present the results for the paired sample t-test analyses. Lastly, the results of 
the regression models assessing the relationship between interruptions in gender-
affirming care and pandemic anxiety and depression will be presented. 
4.1 Objective 1: descriptive characteristics of the sample 
This section will present the characteristics of the sample population as well as the 
characteristics of TGNB individuals experiencing interruptions in gender-affirming 
medical care during the COVID-19 pandemic. 
4.1.1 Descriptive characteristics of the total sample population 
Descriptive statistics for the total analytic sample (N=611) are presented in Table 2. The 
sample sizes (N) are unweighted and the proportions and confidence intervals presented 
are weighted. There were three age groups that participants predominantly belonged to, 
which were the 20-24 age group (20.0%, 95% CI: 16.5, 23.5), 25-34 age group (34.2%, 
95% CI: 30.2, 38.3), and 35-49 age group (24.3%, 95% CI: 20.7, 27.9). Gender identity 
was relatively equally dispersed among three groups with 32.5% (95% CI: 28.4, 36.6) 
identifying as woman/girl, 33.6% (95% CI: 29.4, 37.7) as man/boy and 32.1% (95% CI: 
28.1, 36.0) as non-binary or similar. A small proportion identified as Indigenous or other 
cultural identity (1.9%, 95% CI: 0.8, 2.9). The analytic sample had a higher proportion of 
participants assigned female at birth (61.1%, 95% CI: 56.9, 65.4) compared to assigned 
male at birth (38.9%, 95% CI: 34.6, 43.1). Study participants mainly lived in Ontario 
(34.4%, 95% CI: 30.4, 38.4) and British Columbia (20.1%, 95% CI: 16.8, 23.4), with the 
smallest proportion living in the territories (0.1%, 95% CI: 0.0, 0.3). Most individuals 
lived in census metropolitan areas (93.5%, 95% CI: 91.2, 95.7) with 6.5% (95% CI: 4.3, 
8.8) living in rural areas or small towns. Approximately 7.7% (95% CI: 5.1, 10.2) were 
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Indigenous and 10.4% (95% CI: 7.8, 13.0) of individuals were racialized (perceived or 
identified as a person of colour). A relatively small proportion of individuals were 
immigrants to Canada (10.6%, 95% CI: 8.2, 13.1). Participants were generally well 
educated with 39.8% (95% CI: 35.7, 44.0) having completed a college or university 
degree with another 25.9% (95% CI: 22.1, 29.7) having completed some college, 
university or Collège d'enseignement general et professionnel (CEGEP). For total 
personal income (before taxes), about one fifth of respondents reported no personal 
annual income (19.3%, 95% CI: 15.7, 22.8), with most reporting an income of less than 
$15,000 (27.1%, 95% CI: 23.2, 31.0) and between the income bracket of $15,000 to 
$29,999 (21.0%, 95% CI:17.5, 24.5). 
Table 2 
Characteristics of the participants in the analytic sample (N=611) 
Characteristica Unweighted N Weighted % (95% CI) 
Age 
  15-19 49  11.5 (8.4, 14.7) 
  20-24 113  20.0 (16.5, 23.5) 
  25-34 215  34.2 (30.2, 38.3) 
  35-49 172  24.3 (20.7, 27.9) 
  50-64 49  8.1 (5.8, 10.4) 
  65+ 9  1.8 (0.6, 3.0) 
Gender 
  Woman or girl 192  32.5 (28.4, 36.6) 
  Man or boy 192  33.6 (29.4, 37.7) 
  Indigenous or other cultural identity 12  1.9 (0.8, 2.9) 
  Non-binary or similar  214  32.1 (28.1, 36.0) 
Sex assigned at birth 
  Male  230  38.9 (34.6, 43.1) 
  Female  376  61.1 (56.9, 65.4) 
Province/territory 
  British Columbia  134  20.1 (16.8, 23.4) 
  Alberta  115  19.2 (15.8, 22.6) 
  Saskatchewan  18  3.1 (1.5, 4.6) 
  Manitoba  21  3.0 (1.7, 4.3) 
  Ontario 230  34.4 (30.4, 38.4) 
  Quebec  59  15.0 (11.3, 18.8) 
  New Brunswick 9  1.5 (0.5, 2.5) 
  Prince Edward Island 4  0.5 (0.0, 1.0) 
  Nova Scotia 16  2.4 (1.2, 3.7) 
  Newfoundland and Labrador 4  0.7 (0.0, 1.5) 
  NWT/Nunavut/Yukon  1  0.1 (0.0, 0.3) 
Indigenous status 
  Indigenous 38  7.7 (5.1, 10.2) 




  Racialized 66  10.4 (7.8, 13.0) 
  Not racialized 543  89.6 (87.0, 92.2) 
Immigration history 
  Immigrant  75  10.6 (8.2, 13.1) 
  Not an immigrant  536  89.4 (86.9, 91.8) 
Urban/rural 
  Living in a rural area/small town 36  6.5 (4.3, 8.8) 
  Not living in a rural area/small town 574  93.5 (91.2, 95.7) 
Education 
  < High school  38  10.3 (7.1, 13.5) 
  High school diploma  55  11.7 (8.6, 14.7) 
  Some college or university or CEGEP  155  25.9 (22.1, 29.7) 
  College or university degree 264  39.8 (35.7, 44.0) 
  Grad/professional degree  99  12.3 (9.8, 14.9) 
Personal annual income in 2019 
  No personal annual income  106  19.3 (15.7, 22.8) 
  < $15,000  163  27.1 (23.2, 31.0) 
  $15,000 - $29,999   127  21.0 (17.5, 24.5) 
  $30,000 - $49,999 83  13.7 (10.7, 16.7) 
  $50,000 - $79,999  73  10.8 (8.3, 13.4) 
  $80,000 +  48  8.1 (5.7, 10.6) 
a 
Characteristics were reported from the 2020 survey data  
b This includes those who are perceived/treated or identify as people of colour  
4.1.2 Descriptive characteristics by interruptions in gender-affirming 
care groupings 
Table 3 represents the descriptive characteristics of participants by interruptions in 
gender-affirming care groupings. Unweighted sample sizes (N) are presented with 
weighted proportions and confidence intervals. Of the total analytic sample, there were 
149 participants (Weighted %: 23.9%) who experienced interruptions in hormones 
(including inability to get a new prescription or referral). Approximately half of these 
individuals were between the ages of 25 to 49 (49.5%, 95% CI: 40.8, 58.2) with most of 
them living in Ontario (36.2%, 95% CI: 28.0, 44.5), British Columbia (17.2%, 95% CI: 
10.7, 23.6), or Alberta (19.1%, 95% CI: 12.3, 25.8). There were 7.0% (95% CI: 2.4, 11.7) 
who also lived in a rural area or small town. Of those who experienced interruptions in 
hormones, 39.1% (95% CI: 30.4, 47.7) identified as a man or boy, 29.9% (95% CI: 21.7, 
38.0) identified as a woman or girl, and 29.5% (95% CI: 22.1, 37.0) as non-binary, 
genderqueer or an identity similar; 1.5% (95% CI: 0.0, 3.3) identified as Indigenous or 
another cultural identity. Most participants had received the gender-affirming medical 
treatment that they needed/wanted (45.1%, 95% CI: 36.4, 53.8) or were in the process of 
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completing gender-affirming medical treatment pre-pandemic (44.4%, 95% CI: 35.8, 
53.0).  
There were 23 participants (Weighted %: 3.3%) who experienced a surgical interruption 
during the COVID-19 pandemic. This group largely consisted of individuals between the 
ages of 25 to 49 (70.0%, 95% CI: 50.8, 89.2), and all were not living in a rural area or 
small town (100%, 95% CI: 100.0, 100.0). Similar to those who experienced 
interruptions in hormones, those who had surgical interruptions largely lived in British 
Columbia (34.8%, 95% CI: 14.9, 54.7), Ontario (30.5%, 95% CI: 11.9, 49.1) or Alberta 
(20.0%, 95% CI: 2.1, 37.9). There were 36.1% (95% CI: 15.7, 56.5) who identified as a 
woman/girl, 38.6% (95% CI: 17.9, 59.3) who identified as a man or boy and 25.4% (95% 
CI: 8.2, 42.6) who identified as non-binary, genderqueer or an identity similar. In terms 
of pre-pandemic gender-affirming care status, most participants were in the process of 
completing gender-affirming medical treatment (95.2%, 95% CI: 86.0, 100.0).  
Interruptions in surgery and hormones was the smallest subgroup with 18 participants 
(Weighted %: 2.5%) who had experienced an interruption in both treatments. More than 
two-thirds of individuals were between the ages of 25 to 49 (70.2%, 95% CI: 48.2, 92.2). 
Over half of the group identified as a man or boy (58.8%, 95% CI: 35.8, 81.8), 4.6% 
(95% CI: 0.0, 13.5) identified as a woman or girl, 29.3% (95% CI: 8.7, 49.8) identified as 
non-binary, genderqueer or a similar identity and 7.3% (95% CI: 0.0, 20.9) identified as 
Indigenous or another cultural identity. Almost half of the subgroup resided in Ontario 
(47.3%, 95% CI: 23.8, 70.8) with most of the other individuals living in either British 
Columbia (16.8%, 95% CI: 0.0, 34.4) or Alberta (15.8%, 95% CI: 0.0, 32.5). There were 
also 12.9% (95% CI: 0.0, 29.5) living in a rural area or small town. Most individuals in 
this group were in the process of completing gender-affirming medical treatment (94.4%, 
95% CI: 83.7, 100.0).  
The final subgroup consisted of participants who did not experience interruptions in 
gender-affirming medical care (N=421, Weighted %: 70.3%). There were 60.7% (95% 
CI: 55.4, 66.0) of individuals in the 25 to 49 age group, 27.5% (95% CI: 22.5, 32.5) in the 
14 to 24 age group and 11.7% (95% CI: 8.4, 15.1) in the 50+ age group. The proportion 
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of participants who identified as woman or girl (34.2%, 95% CI: 29.2, 39.2), man or boy 
(30.6%, 95% CI: 25.7, 35.5) and non-binary or similar (33.4%, 95% CI: 28.4, 38.3) was 
relatively similar. Only 1.9% (95% CI: 0.5, 3.2) identified as Indigenous or another 
cultural identity. Those who did not experience interruptions in care largely resided in 
British Columbia (20.6%. 95% CI: 16.6, 24.6), Alberta (19.3%, 95% CI: 15.1, 23.4), 
Ontario (33.5%, 95% CI: 28.7, 38.3), and Quebec (16.7%, 95% CI: 12.0, 21.4). Most 
individuals in this group lived in census metropolitan areas (93.5%, 95% CI: 90.9, 96.2). 
In terms of pre-pandemic gender-affirming care status, almost half the participants had 
received the gender-affirming medical care that they needed or wanted (49.8%, 95% CI: 
44.6, 55.1), while 37.7% (95% CI: 32.7, 42.7) were in the process and 12.5% (95% CI: 
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  14-24  
162 31.5 
27.3, 
35.7 60 45.3 
36.6, 
54.0 5 21.2 
4.1, 
38.3 4 24.0 
3.3, 
44.8 93 27.5 
22.5, 
32.5 
  25-49  
387 58.6 
54.2, 
62.9 81 49.5 
40.8, 
58.2 16 70.0 
50.8, 
89.2 13 70.2 
48.2, 
92.2 277 60.7 
55.4, 
66.0 
  50+ 
58 9.9 
7.3, 
12.5 8 5.2 
1.6, 
8.8 2 8.8 
0.0, 
20.6 1 5.8 
0.0, 




  Woman/girl 
192 32.5 
28.4, 
36.6 40 29.9 
21.7, 
38.0 8 36.1 
15.7, 
56.5 1 4.6 
0.0, 
13.5 143 34.2 
29.2, 
39.2 
  Man/boy 
192 33.6 
29.4, 
37.7 53 39.1 
30.4, 
47.7 8 38.6 
17.9, 
59.3 10 58.8 
35.8, 
81.8 121 30.6 
25.7, 
35.5 
  Indigenous/other  
  cultural identity 12 1.8 
0.8, 
2.9 3 1.5 
0.0 
,3.3 0 0 - 1 7.3 
0.0, 
20.9 8 1.9 
0.5, 
3.2 
  Non-binary,    
  genderqueer or    
  similar 214 32.1 
28.1, 
36.0 52 29.5 
22.1, 
37.0 7 25.4 
8.2, 
42.6 6 29.3 
8.7, 




  BC 
134 20.1 
16.8, 
23.4 27 17.2 
10.7, 
23.6 8 34.8 
14.9, 
54.7 3 16.8 
0.0, 
34.4 96 20.6 
16.6, 
24.6 
  AB 
115 19.2 
15.8, 
22.6 29 19.1 
12.3, 
25.8 4 20.0 
2.1, 
37.9 3 15.8 
0.0, 
32.5 79 19.3 
15.1, 
23.4 
  SK 
18 3.1 
1.5, 
4.6 5 2.5 
0.3, 
4.8 1 5.3 
0.0, 





  MB 
21 3.0 
1.7, 
4.3 8 5.3 
1.6, 
9.1 1 4.8 
0.0, 
14.0 0 0 - 12 2.2 
0.9, 
3.5 
  ON 
230 34.4 
30.4, 
38.4 56 36.2 
28.0, 
44.5 8 30.5 
11.9, 
49.1 9 47.3 
23.8, 
70.8 157 33.5 
28.7, 
38.3 
  QC 
59 15.0 
11.3, 
18.8 14 13.0 
6.2, 
19.9 1 4.6 
0.0, 
13.5 0 0 - 44 16.7 
12.0, 
21.4 
  NB 
9 1.5 
0.5, 
2.5 2 1.0 
0.0, 
2.5 0 0 - 1 7.6 
0.0, 
21.9 6 1.5 
0.3, 
2.7 
  PEI 
4 0.5 
0.0, 
1.0 0 0 - 0 0 - 0 0 - 4 0.7 
0.0, 
1.4 
  NS 
16 2.4 
1.2, 
3.7 6 4.5 
0.9, 
8.1 0 0 - 2 12.5 
0.0, 
29.3 8 1.5 
0.5, 
2.6 
  NL 
4 0.7 
0.0, 
1.5 2 1.2 
0.0, 
3.0 0 0 - 0 0 - 2 0.6 
0.0, 
1.5 
  YT/NWT/NU 
1 0.1 
0.0, 




  Living in a rural    
  area/small town 36 6.5 
4.3, 
8.8 9 7.0 
2.4, 
11.7 0 0 - 2 12.9 
0.0, 
29.5 25 6.5 
3.8, 
9.1 
  Not living in a  
  rural area/small  
  town 574 93.5 
91.2, 
95.7 140 93.0 
88.3, 
97.6 23 100.0 
100.0, 
100.0 16 87.1 
70.5, 




affirming care (GAC)  
status 
  Have had GAC 
  that I need/want 280 45.8 
41.5, 
50.1 68 45.1 
36.4, 
53.8 0 0 - 0 0 - 212 49.8 
44.6, 
55.1 
  In the process of 
  completing GAC 275 42.6 
38.3, 
46.8 67 44.4 
35.8, 
53.0 22 95.2 
86.0, 
100.0 17 94.4 
83.7, 
100.0 169 37.7 
32.7, 
42.7 
  Planning to  
  receive GAC (not 
  begun) 56 11.6 
8.6, 
14.7 14 10.5 
5.1, 
16.0 1 4.8 
0.0, 
14.0 1 5.6 
0.0, 
16.3 40 12.5 
8.7, 
16.4 
a Includes those who had interruptions in taking hormones or those who were unable to get a new prescription or referral for hormones  
b These are unweighted N’s with weighted proportions 
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4.2 Objective 2: describing interruptions in gender-affirming 
medical care during the COVID-19 pandemic 
Gender-affirming care status in 2020 and descriptive characteristics pertaining to 
interruptions in care are presented in Table 4. Unweighted sample sizes (N) are presented 
with weighted frequencies and confidence intervals. Most participants had received the 
gender-affirming care that they needed/wanted (45.8%, 95% CI: 41.5, 50.1) or were in 
the process of completing care (42.6%, 95% CI: 38.3, 46.8) in 2020. There were 500 
participants who were taking hormones (91.6%, 95% CI: 89.3, 93.8) and 473 who had 
access to hormones at the time of taking the survey (94.6%, 95% CI: 92.4, 96.7). Since 
March 12, 2020, 26.9% (95% CI: 22.7, 31.1) of participants experienced interruptions in 
hormones. The most frequently cited reasons for inability to access hormones were drug 
shortages (52.4%, 95% CI: 43.3, 61.5), inability to get a prescription renewed (39.2%, 
95% CI: 30.3, 48.2), and inability to go to the pharmacy (20.5%, 95% CI: 12.9, 28.0). 
Since March 12, 2020, 14.3% (95% CI: 10.3, 18.2) of participants were unable to get a 
new prescription or referral for hormones. Of these, approximately half reported that it 
was due to restrictions related to COVID-19 (47.6%, 95% CI: 32.4, 62.8). 18.2% (95% 
CI: 14.0, 22.5) of the sample had an appointment booked to have gender-affirming 
surgery, of which approximately half had their appointment cancelled or postponed due 
to COVID-19 (58.3%, 95% CI: 45.2, 71.4). The three most common surgeries that were 
cancelled or postponed were chest surgery (50.9%, 95% CI: 34.6, 67.3), genital gender-
affirming surgery (33.0%, 95% CI: 17.4, 48.5), and a hysterectomy or oophorectomy 
(23.9%, 95% CI: 9.7, 38.1). Of those who had a surgical interruption, 37.5% (95% CI: 
21.6, 53.5) had an alternative date set for the surgery and 19.9% (95% CI: 6.6, 33.2) had 
the surgery since the initial cancellation. Participants had also experienced some 
limitations in accessing additional aspects of gender-affirming health care due to 
COVID-19, such as access to binders, packers or gaffs (14.3%, 95% CI: 9.9, 18.7), non-
medical supplies (14.4%, 95% CI: 10.7, 18.0), postoperative medical supplies (6.1%, 
95% CI: 2.1, 10.2), and post-operative care following gender-affirming surgery (21.6%, 





Gender-Affirming Care Status and Interruptions in Care due to COVID-19 (N=611) 
 
 






Weighted % (95% CI) 
GAC status in 2020 
  Have had GAC that I need/want 280 45.8 (41.5, 50.1) 
  In the process of completing GAC 275 42.6 (38.3, 46.8) 
  Planning to receive GAC (not begun) 56 11.6 (8.6, 14.7) 
Taking hormones a  
  Yes 500 91.6 (89.3, 93.8) 
  No 55 8.4 (6.2, 10.7) 
Access to hormones currently b 
  Yes 473 94.6 (92.4, 96.7) 
  No 27 5.4 (3.3, 7.6) 
Interruptions in hormones since March 12, 2020 b  
  Yes 139 26.9 (22.7, 31.1) 
  No 361 73.1 (68.9, 77.3) 
Reasons for inability to access hormones c 
  Couldn’t’ afford it 12 8.8 (3.7, 13.9) 
  Couldn’t go to the pharmacy 27 20.5 (12.9, 28.0) 
  Couldn’t get my prescription renewed 53 39.2 (30.3, 48.2) 
  Couldn’t get syringes or needles 13 7.9 (3.5, 12.2) 
  Drug shortages 77 52.4 (43.3, 61.5) 
  Nobody to help with injections 11 6.5 (2.6, 10.5) 
  People in my household couldn’t know I’m taking   




1.0 (0.0, 2.4) 
  Other 11 9.7 (3.7, 15.6) 
Unable to get a new prescription or referral for  
hormones since March 12, 2020 d 
  Yes 48 14.3 (10.3,18.2) 
  No 210 62.2 (56.5, 67.9) 
  Haven’t needed it during this time 71 23.5 (18.3, 28.7) 
Unable due to restrictions related to COVID-19 e  
  Yes 24 47.6 (32.4, 62.8) 
  No 24 52.4 (37.2, 67.6) 
Before March 12 2020, had appointment booked to 
have gender-affirming surgery d  
  Yes 67 18.2 (14.0, 22.5) 
  No 264 81.8 (77.5, 86.0) 
Surgery appointment canceled/postponed due to  
COVID-19 f  
  Yes 41 58.3 (45.2, 71.4) 
  No 14 23.6 (11.8, 35.3) 
  Not yet, but I expect it will 12 18.1 (7.6, 28.6) 
Alternative date set for surgery g 
  Yes 15 37.5 (21.6, 53.5) 
  No 26 62.5 (46.5, 78.4) 
Type of surgery that was cancelled/postponed g  
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  Chest surgery 22 50.9 (34.6, 67.3) 
  Genital gender-affirming surgery 13 33.0 (17.4, 48.5) 
  Removal of uterus (hysterectomy) or removal of  




23.9 (9.7, 38.1) 
  Voice surgery 0 0 
  Adam’s apple surgery 2 4.9 (0.0, 11.8) 
  Facial surgery 1 2.4 (0.0, 7.3) 
  Other surgery 0 0 
Had surgery since initial cancellation g  
  Yes 8 19.9 (6.6, 33.2) 
  No 33 80.1 (66.8, 93.4) 
COVID-19 limited access to aspects of gender- 
affirming health care h 
  Binders, packers, or gaffs (n=293) 42 14.3 (9.9, 18.7) 
  Non-medical supplies (e.g., makeup, shaving  




14.4 (10.7, 18.0) 
  Medical material that is important after surgery (e.g.  




6.1 (2.1, 10.2) 
  Post-operative care following gender-affirming  




21.6 (15.4, 27.8) 
a Only asked to those who have had the GAC they need/want or are in the process of completing GAC 
(n=555) 
b Only asked to those who said they take hormones (n=500) 
c Asked to those who had interruptions in hormones since March 12, 2020 (n=139) 
d Asked to those who are in the process of completing GAC or are planning to receive GAC but have not 
begun (n=331)   
e Only asked to those who were unable to get a new prescription or referral for hormones since March 12, 
2020 (n=48) 
f Only asked to those who had an appointment booked to have gender-affirming surgery before March 12, 
2020 (n=67) 
g Only asked to those who had a surgery appointment cancelled or postponed due to COVID-19 (n=41) 
h Asked amongst the participants for whom this was applicable to  
4.3 Objective 3: paired sample t-test analyses for anxiety 
and depression 
Pre-pandemic and pandemic anxiety and depression statistics are presented in Table 5. 
The OASIS was used to measure self-reported anxiety levels with a possible score range 
of 0 to 20. The CES-D-10 was used to measure self-reported depression levels (possible 
score range of 0 to 30). The average pre-pandemic anxiety score was 10.17 (SD=4.12), 
and the average pre-pandemic depression score was 14.30 (SD=6.74). In terms of 
pandemic scores, the average anxiety and depression scores were 10.38 (SD=3.98) and 
16.41 (SD=6.56), respectively. We also looked at the prevalence of those who were likely 
experiencing clinical depression during both the pre-pandemic and pandemic periods, and 
it was determined that 71.1% and 83.1% of our sample was experiencing depressive 
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symptoms that are consistent with clinical depression, respectively. In regards to pre-
pandemic and pandemic anxiety prevalence, 76.7% and 77.6% of respondents had a 
probable anxiety disorder, respectively.  
Table 5 






Error of the 
Mean 
95% CI for Mean 
Lower Upper 
Pre-pandemic anxiety 10.17 4.12 0.20 9.77 10.57 
Pandemic anxiety 10.38 3.98 0.19 10.02 10.74 
Pre-pandemic depression 14.30 6.74 0.31 13.70 14.91 
Pandemic depression 16.41 6.56 0.30 15.83 17.00 
 
In Table 6, a paired sample t-test is presented which was used to evaluate whether there 
was a significant difference in anxiety scores from pre-pandemic anxiety to pandemic 
anxiety. On average, the pandemic anxiety scores were 0.29 points (SD= 3.20, 95% CI: -
0.02, 0.61) higher than the pre-pandemic anxiety scores. However, this difference was 
not statistically significant (t= 1.84, p= 0.0657) and it is concluded that there is no 
evidence from unadjusted analysis to suggest that TGNB persons are experiencing 
greater levels of pandemic anxiety compared to pre-pandemic anxiety. 
 
A paired sample t-test was also used to assess if there was a difference in depression 
scores from pre-pandemic depression to pandemic depression and this is displayed in 
Table 6. On average, the pandemic depression scores were 2.23 points (SD= 5.95, 95% 
CI: 1.69, 2.76) higher than the pre-pandemic depression scores. There is evidence to 
suggest that depression scores changed from pre-pandemic to pandemic (t= 8.15, p 
<0.0001) and that on average, TGNB persons are experiencing greater depressive 





Paired t-test assessing the difference in anxiety and depression scores from pre-pandemic 






















































anxiety 0.29 3.20 0.16 -0.02 0.61 1.84 0.0657 
Post-pre 
depression 2.23 5.95 0.27 1.69 2.76 8.15 <0.0001 
4.4 Objective 4: regression analyses of interruptions in 
gender-affirming care and anxiety 
4.4.1 Model 1— interruptions in gender-affirming medical care as a 
predictor of pandemic anxiety (adjusting for pre-pandemic 
anxiety) 
The linear regression analysis between the exposure, interruptions in gender-affirming 
care and the outcome, pandemic anxiety, is presented in Table 7 as Model A. Compared 
to the reference group—those who did not have interruptions in gender-affirming care—
interruptions in taking hormones was not significantly associated with pandemic anxiety 
after adjusting for pre-pandemic anxiety (β=0.59, p=0.0577). Additionally, compared to 
the reference group, there was also no statistically significant association between 
surgical interruptions (β=-0.43, p=0.4684) or interruptions in taking hormones and 
surgical interruptions (β=1.49, p=0.0539) and pandemic anxiety after adjusting for pre-
pandemic anxiety. The R2 value was 0.4747; therefore, interruptions in gender-affirming 




4.4.2 Model 2— interruptions in gender-affirming medical care as a 
predictor of pandemic anxiety, assessing for an interaction 
between interruptions in care and pre-pandemic anxiety 
levels and adjusting for other potential confounders 
The second model involved conducting a multiple linear regression to assess whether 
there was a significant association between the exposure and outcome after adjusting for 
confounders and with the addition of an interaction between pre-pandemic anxiety and 
interruptions in care. The confounders that were adjusted for include: income changes 
due to COVID-19, current geographic location, current social support, educational 
attainment, COVID-19 related health concerns, low-income household, pre-pandemic 
anxiety and depression, and pre-pandemic gender-affirming care status. This model 
yielded similar results to the first model; after controlling for the covariates, all three 
interruption categories—interruptions in taking hormones (β=1.62, p=0.1102), surgical 
interruptions (β=-0.96, p=0.5546) and interruptions in taking hormones and surgical 
interruptions (β=0.52, p=0.8493)—were not significantly associated with pandemic 
anxiety when compared to the reference group no interruptions in care. There also was no 
statistically significant interaction observed between interruptions in care and pre-
pandemic anxiety. Therefore, the interaction was removed from the final multiple linear 
regression model (Model 3). 
4.4.3 Model 3— interruptions in gender-affirming medical care as a 
predictor of pandemic anxiety, adjusting for pre-pandemic 
anxiety and other potential confounders 
A multiple linear regression was conducted with interruptions in care, pandemic anxiety 
and potential confounders which included income changes due to COVID-19, current 
geographic location, current social support, educational attainment, COVID-19 related 
health concerns, low-income household, pre-pandemic anxiety and depression and pre-
pandemic gender-affirming care status. The results are reported in Table 7 as Model B. 
Similar to the first model, after adjusting for additional confounders, the results revealed 
that there were no observed associations between interruptions in taking hormones 
(β=0.50, p=0.0892), surgical interruptions (β=-0.95, p= 0.1124) or interruptions in both 
hormones and surgery (β=1.28, p=0.0826) with pandemic anxiety when compared to the 
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reference group. The model fit was improved from the first model with more variance 
being explained with the addition of the independent variables (R2=0.5489). 
Table 7 
Anxiety regression models (N=611) 













p value R2 
No 
interruptions 
Reference group Reference group 
Interruptions 
in taking 
hormones 0.59 0.31 1.90 0.0577 0.4747 0.50 0.30 1.70 0.0892 0.5489 
Surgical 





interruptions 1.49 0.77 1.93 0.0539  1.28 0.74 1.74 0.0826  
Pre-pandemic 
anxiety 0.64 0.04 16.96 <0.0001  0.54 0.05 11.00 <0.0001  
a Adjusting for pre-pandemic anxiety 
b Adjusting for the following minimum sufficient set of confounders: income changes due to COVID-19, 
current geographic location, current social support, educational attainment, COVID-19 related health 




4.5 Objective 5: regression analyses of interruptions in 
gender-affirming care and depression 
4.5.1 Model 1— interruptions in gender-affirming medical care as a 
predictor of pandemic depression (adjusting for pre-
pandemic depression) 
The results for this model are presented in Table 8 as Model C. The 2019 depression-
adjusted association between interruptions in care and pandemic depression is reported 
with the interaction term for comparison, as the interaction was significant in further, 
adjusted models. There were no significant associations between having a surgical 
interruption or having both a surgical and hormonal interruption with pandemic 
depression. However, participants who experienced an interruption in taking hormones 
with a pre-pandemic depression score of 0, had on average a 3.77-point increase in 
pandemic depression score compared to those who had no interruptions in care (β= 3.77, 
p=0.0270).  
For every one-unit increase in pre-pandemic depression score, the pandemic depression 
score decreased by 0.16 points for individuals who experienced hormonal interruptions 
compared to those who had no interruptions (β =-0.16, p=0.1087). This interaction was 
not significant in this model, however, values at different levels of pre-pandemic 
depression are presented for interpretability. For those who experienced an interruption in 
taking hormones with a pre-pandemic depression score of 14.30 (the sample mean), there 
was a 1.48-point increase in pandemic depression score compared to those who had no 
interruptions in care. For TGNB persons who experienced interruptions in hormonal care 
and had a pre-pandemic depression score of 21.04 (mean + 1SD), there was a 0.40-point 
increase in pandemic depression relative to those who had no interruptions. Lastly, for 
participants who had a hormonal interruption and a pre-pandemic depression score of 
7.56 (mean – 1SD), there was a 2.56-point increase in pandemic depression compared to 





4.5.2 Model 2—— interruptions in gender-affirming medical care as a 
predictor of pandemic depression, assessing for an 
interaction between interruptions in care and pre-pandemic 
depression and adjusting for other potential confounders 
The confounder-adjusted results are presented in Table 8 as Model D. The minimum 
sufficient set of confounders that were adjusted for included income changes due to 
COVID-19, current geographic location, current social support, educational attainment, 
COVID-19 related health concerns, low-income household, pre-pandemic anxiety and 
depression and pre-pandemic gender-affirming care status. Consistent with the first 
model, in comparison to those who had no interruptions in care, there were no significant 
associations between having a surgical interruption or having both a surgical and 
hormonal interruption with pandemic depression after adjusting for additional 
confounders. However, after adjustment, participants who experienced an interruption in 
taking hormones with a pre-pandemic depression score of 0 had on average a 3.54-point 
increase in pandemic depression score compared to those who had no interruptions in 
care (β= 3.54, p=0.0115). After adjustment, for every one-unit increase in pre-pandemic 
depression score, the pandemic depression score decreased by 0.16 points for those who 
experienced hormonal interruptions compared to those who had no interruptions (β =-
0.16, p=0.0344). After adjusting for additional confounders in this model, the interaction 
became significant.  
For TGNB persons who experienced interruptions in hormones and had a pre-pandemic 
depression score of 14.30 (the sample mean), there was a 1.25-point increase in pandemic 
depression compared to those who had no interruptions, after adjustment of confounders. 
For individuals who had hormonal interruptions and a pre-pandemic depression score of 
21.04 (mean + 1SD), there was a 0.17-point increase in pandemic depression score 
relative to persons who had no interruptions, after adjustment. Lastly, compared to those 
who had no interruptions, individuals who experienced an interruption in hormones with 
a pre-pandemic score of 7.56 (mean – 1SD), had a 2.33-point increase in pandemic 
depression after adjusting for confounders. With the additional covariates, the model fit 
was improved in this model as the independent variables explained more variation in the 




Depression regression models (N=611) 













p value R2 
No 
interruptions 
Reference group Reference group 
Interruptions 
in taking 
hormones 3.77 1.71 2.21 0.0270 0.3644 3.54 1.40 2.53 0.0115 0.4900 
Surgical 





interruptions 2.22 3.23 0.69 0.4916  0.96 2.38 0.40 0.6864  
Pre-pandemic 





















Reference group Reference group 
a Adjusting for pre-pandemic depression 
b Adjusting for the following minimum sufficient set of confounders: income changes due to COVID-19, 
current geographic location, current social support, educational attainment, COVID-19 related health 
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concerns, low-income household, pre-pandemic anxiety and depression, pre-pandemic gender-affirming 
care status 
4.5.3 Model 3— interruptions in gender-affirming medical care as a 
predictor of pandemic depression, adjusting for pre-
pandemic depression and other potential confounders 
After testing for an interaction in Model 2, we concluded that one of the interactions was 
indeed significant, therefore, the main effects model (Model 3) would be misspecified. 
As a result, this multiple linear regression model was not conducted since the interaction 
term was significant in the previous model.
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Chapter 5  
5 Discussion 
This chapter will discuss the findings of both the descriptive and regression analyses 
while also discussing how our results integrate with the previous literature on COVID-19 
and transgender health. It will also discuss the strengths and limitation of the current 
study along with recommendations for future research. 
5.1 Summary of results 
5.1.1 Changes in anxiety and depression symptoms from pre-
pandemic to pandemic periods 
For depression, a cut-point of ten or higher indicates the presence of significant 
depressive symptoms (Andresen et al., 1994). It is important to note that CES-D-10 
measures depressive symptoms that are consistent with clinical depression and that this 
cut-point might not indicate a clinical diagnosis of depression in and of itself. In our 
study sample, the average pre-pandemic and pandemic depression scores were well above 
the cut-point of ten. Moreover, there was also a high proportion of individuals crossing 
this cut-point for both time periods, with an even greater prevalence of probable clinical 
depression during the pandemic period. This suggests that on average, TGNB persons in 
our study are experiencing high levels of depressive symptomology that may be 
consistent with clinical depression. However, it is also important to note that this 
established cut-point might not map onto clinical depression the same way within TGNB 
communities. Although this scale is increasingly being used in this population, it is 
important to note that there are no prior studies that have assessed whether these 
measurement properties hold in the TGNB population. Therefore, even though a high 
proportion might cross this threshold, it might not indicate that all these individuals are 
indeed clinically depressed. Our findings that our sample presented with relatively high 
levels of depression symptoms is consistent with previous literature (Rotondi, Bauer, 
Travers, et al., 2011; Rotondi, Bauer, Scanlon, et al., 2011; Veale, Peter, Travers et al., 
2017; Pitts et al., 2009).  
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For anxiety, a cut-point of eight or higher is indicative of a probable anxiety disorder 
(Campbell-Sills et al., 2009). In our study sample, the average pre-pandemic and 
pandemic anxiety scores were both above the cut-point of eight. Moreover, we 
determined that there was a high prevalence of individuals crossing this cut-point value 
both prior and during the pandemic. This suggests that on average, TGNB persons in our 
study are experiencing anxiety severity that could be classified as an anxiety diagnosis. 
Our findings are consistent with previous literature that has found that anxiety levels are 
heightened in TGNB populations (Jaffray, 2020; Smith et al., 2014; McNeil et al., 2012). 
Overall, this study supports previous findings that TGNB persons are experiencing a 
disproportionally high level of anxiety and depression.  
Our paired sample t-test analyses revealed that on average, TGNB persons in our sample 
were not experiencing greater levels of pandemic anxiety compared to pre-pandemic 
anxiety. However, there is evidence indicating that TGNB individuals were experiencing 
greater pandemic depressive symptomology compared to pre-pandemic; pandemic 
depression scores were significantly higher by an average of 2.23 points. This is an 
interesting finding as we had hypothesized that both anxiety and depression levels would 
be heightened amidst the pandemic. Aligned with our study findings, a U.S. based 
longitudinal cohort study reported that on average, psychological distress was higher 
during the pandemic compared to pre-pandemic (Kidd et al., 2021). Another study of 161 
TGNB youth in the U.K. revealed that several youths qualitatively reported that their 
anxiety and depressive symptoms were exacerbated during the pandemic; however, some 
youth also reported that their mental health improved during the pandemic due to having 
more free time to work on their mental well-being, as well as having reduced social 
anxiety (Jones et al., 2021). Therefore, although some pandemic-related changes could 
have increased anxiety levels, it is also possible that some TGNB persons in our sample 
were not as anxious in other aspects of their lives (e.g., social) during the pandemic; this 
could explain why anxiety levels did not fluctuate much. The PRIDE longitudinal study 
reported that among the 2288 SGM persons included in their study, depression and 
anxiety symptoms increased from pre-pandemic to post-pandemic (Flentje et al., 2020). 
However, they also mentioned that among those who screened positive for anxiety pre-
pandemic, there was no significant change in anxiety. Considering that on average, our 
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sample also consisted of participants with a probable anxiety disorder pre-pandemic and 
there was no significant change in anxiety score, it is possible that the pandemic 
measures did not alter anxiety levels for some TGNB persons who were already 
experiencing anxiety symptoms consistent with a probable anxiety disorder pre-
pandemic.  
Previous literature has demonstrated that negative or stressful life events are associated 
with increases in anxious arousal—defined as symptoms of hyperarousal that are specific 
to anxiety—and anxiety sensitivity (McLaughlin & Hatzenbuehler, 2009; Wardenaar et 
al., 2014). Specifically, McLaughlin & Hatzenbuehler (2009) mentioned that stressful life 
events, in particular events that are related to health, were associated with heightened 
anxiety sensitivity. Given that pandemic-related changes—such as interruptions in 
gender-affirming care—could have resulted in stressful experiences for TGNB persons, 
we would have expected changes in anxiety severity from the pre-pandemic to pandemic 
periods. 
5.1.2 Descriptive characteristics of the sample population 
In the total sample population, over half the sample was within the age groups of 25-34 
and 35-49 years, a greater proportion were assigned female at birth, and participants 
largely lived in Ontario, British Columbia or Alberta, and were from census metropolitan 
areas. Considering that these are more of the heavily populated provinces in Canada, it is 
not surprising that most participants were living in these regions. Indigenous persons 
account for 4.9% of the general Canadian population (Statistics Canada, 2017a); in 
comparison, the proportion of Indigenous persons in our study was slightly higher 
(7.7%). Although most participants were educated, many did not have a personal annual 
income or were in a lower income bracket. Annual income is largely dependent on an 
individuals’ employment, and the literature has suggested that sexual and gender 
minorities, including TGNB persons, are often susceptible to workplace discrimination 
(Geoffroy & Chamberland, 2015). As a result, this might make it increasingly difficult 
for TGNB persons to find employment or to be promoted to higher positions in their 
workplace. Additionally, the Trans PULSE Ontario project reported other barriers to 
employment for TGNB persons such as, inability to get academic transcripts and 
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references letters that reflect the correct name and gender; some transgender Ontarians 
had also reported declining job offers due to the potential of working in an unsupportive 
environment (Bauer et al., 2011). However, it is also important to note that our sample 
included many youths which might also explain why there were participants who did not 
have a personal annual income. A worldwide cross-sectional study that investigated 
COVID-19 impacts on transgender healthcare also had some similar demographics to our 
study (Koehler et al., 2020). For example, this study had a greater proportion of 
participants assigned female at birth and participants were also generally highly educated 
with almost half the sample having received a college or university degree (Koehler et al., 
2020). It is not surprising that TGNB persons in our study were generally very educated, 
considering that Canadians in general are very educated; over 50% of Canadians between 
the ages of 25 and 64 have completed college or university education (Statistics Canada, 
2017b). 
5.1.3 Descriptive characteristics by interruptions in gender-affirming 
care groupings 
For objective 1, we also described age, gender identity, province/territory, urban/rural 
area of residence, and pre-pandemic gender-affirming care status characteristics by 
interruptions in care groupings. The first group, interruptions in hormones, was the most 
frequently reported interruption in our sample. There is evidence that other populations, 
such as the elderly with chronic diseases, were also experiencing interruptions in 
medications during the pandemic (Hsiao et al., 2020). One of the reasons cited was that 
elderly persons feared getting infected with COVID-19 when picking up their 
prescription; it is possible that some participants in our sample were also experiencing 
hormonal interruptions for this reason. In 2019, most had reported having received the 
gender-affirming care they need/want or were in the process of completing gender-
affirming care. It is important to note that even though participants received the gender-
affirming care they needed in 2019, they were still able to experience an interruption in 
hormones during the pandemic; it is common for TGNB persons to remain on hormone 
therapy for their lifetime to prevent unwanted changes to secondary sex characteristics.   
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The second group, interruptions in surgeries, had a relatively small proportion of 
individuals within it. Most persons were in the process of completing gender-affirming 
care in 2019 with none having reported that they had received the gender-affirming care 
that they needed/wanted. It is plausible that most were in the process of completing 
gender-affirming care in 2019 because they were likely waiting or attempting to schedule 
their gender-affirming surgery during that time. Moreover, among those who experienced 
surgery interruptions, it is possible that there was a high proportion of individuals in the 
25 to 49 age group because youth are unable to schedule a surgery appointment until they 
reach a certain age (usually 18 years), and younger adults may still be deciding whether 
gender-affirming surgery is the right choice for them before starting the process to access 
a surgery. The third group, interruptions in surgery and hormones, had the smallest 
number of participants. Similar to the surgical interruptions group, the interruptions in 
surgery and hormones group also mainly consisted of participants aged 25 to 49, and 
most participants were in the process of completing gender-affirming care in 2019; which 
is expected for the same reasons that were mentioned previously.  
5.1.4 Interruptions in gender-affirming care during the COVID-19 
pandemic 
In 2020, participants in our sample largely reported having received the gender-affirming 
care they needed or that they were in the process of completing gender-affirming care. 
Among those who had the gender-affirming they needed or were in the process of 
completing care, approximately 90% reported that they were taking hormones with close 
to 95% having reported that they had access to hormones at the time of taking the survey. 
However, approximately a quarter of those individuals who were taking hormones 
reported a hormonal interruption since March 12, 2020. Given that this survey was 
administered in October of 2020 and the pandemic was declared in March of 2020, this 
might suggest that those who had experienced interruptions in hormones during the first 
few months of the pandemic were no longer experiencing those interruptions by October 
of 2020. This was before the second wave fully hit in Canada, and so the epidemiological 
situation was likely more favourable with a greater resumption of activities and less 
restrictions across the country. As a result, this might explain why less people reported 
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not having current access to hormones at the time of the survey. However, even with 
taking this into consideration, we still saw an effect of interruptions in hormones on 
pandemic depression.  
The TransCare Covid-19 project—a worldwide cross-sectional survey that predominantly 
consisted of participants from European countries—revealed similar results; of those who 
were accessing hormonal care, 21.8% reported that their current access was restricted 
(Koehler et al., 2020). The most frequently cited reasons for inability to access hormones 
in our study were drug shortages, inability to get prescriptions renewed and inability to 
go to the pharmacy. In contrast to our study, Koehler et al. (2020) reported that the 
inability to get an appointment with a hormone prescriber was the primary reason for 
hormone restrictions, whereas our sample reported drug shortages as the main factor for 
hormonal interruptions. Of those who were taking hormones in our study, approximately 
half the participants cited drug shortages as the reason behind their hormonal 
interruptions (52.4%), whereas 26.2% of the participants in the TransCare Covid-19 
project reported that they had restricted access due to reasons related to hormonal supply. 
It is important to mention that drug shortages were noted in Canada before the onset of 
the pandemic; for example, shortages in injectable drugs, including testosterone, have 
been recognized prior to the pandemic (PHSA, n.d.). Therefore, drug shortages for 
TGNB people could have existed prior to COVID-19. Given that Health Canada has 
reported that there are drug shortages in relation to COVID-19 (Health Canada, 2021), it 
is also possible that the pandemic further exacerbated drug shortages for TGNB persons.  
Another global study that largely consisted of participants from the European and South-
East Asia regions reported that about a third of their sample had reduced access in 
hormones which is relatively similar to our study findings (Jarrett et al., 2021). A U.S. 
study of 208 TGNB persons found that 32.7% of participants experienced delays in 
receiving or starting gender-affirming hormones (Kidd et al., 2021); this is also similar to 
our study findings as almost one third of participants had a hormonal interruption or were 
unable to get a new prescription/referral for hormones. Therefore, hormonal interruptions 
commonly occurred in multiple countries all over the globe; this is not surprising since 
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most countries implemented similar pandemic measures, such as stay-at-home orders, 
which resulted in service disruptions during the pandemic.  
Of those who were in the process or were planning to receive gender-affirming care, 
almost one fifth of participants had an appointment booked to have gender-affirming 
surgery prior to the pandemic. Approximately half of these participants had their surgery 
appointment cancelled or postponed due to COVID-19. This was similar to other 
healthcare treatments in Canada; Chen-See (2020) reported that over 50% of those 
receiving cancer care had their appointments cancelled or rescheduled due to COVID-19.  
In our study, about one third of participants had an alternative date set for the surgery 
with about one fifth having had the surgery since the initial cancellation. These results are 
not surprising considering that surgeries deemed as “non-essential” were largely 
cancelled across Canada; in fact, from March to June 2020, there were approximately 335 
000 fewer surgeries performed in Canada in comparison to the previous year (CIHI, 
2020). Evidently, this has created a massive backlog of elective surgeries that need to be 
rescheduled for a later date (Samson, 2021).  
The most commonly reported surgery cancellation in our study was chest surgery, 
followed by genital gender-affirming surgery and hysterectomy or oophorectomy. 
Previous literature has suggested that top surgeries are much more common compared to 
bottom surgeries among TGNB populations (Nolan et al., 2019). Therefore, it is not 
surprising that within our sample, the cancellation of chest surgeries was most common 
as more participants likely had a chest surgery scheduled relative to other gender-
affirming surgeries.  
The predominantly European TransCare Covid-19 project reported that among 
participants who already had an appointment, 15.6% experienced a surgery cancellation 
or postponement with 19.5% expecting to have a surgery cancellation (Koehler et al., 
2020). Similarly, in our study, 18.1% of participants who had an appointment booked to 
have surgery expected to have a surgery cancellation in the future. Surprisingly, the 
proportion of TGNB persons in Canada who experienced surgical interruptions was over 
three times higher compared to the TransCare Covid-19 study. This could suggest that in 
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general, non-elective surgeries, including gender-affirming surgeries, were cancelled at a 
much higher rate in Canada compared to European countries. A U.S. based study with a 
longitudinal cohort of TGNB persons also revealed that 11.1% of their sample had 
reported a gender-affirming surgery cancellation or postponement (Kidd et al., 2021). 
Overall, these findings are expected because surgeries deemed non-urgent or elective, 
including gender-affirming surgeries, were largely cancelled across the globe amidst the 
pandemic (WHO, 2020a).  
Apart from hormonal and surgical interruptions, TGNB persons in our sample also 
reported limited access to other aspects of gender-affirming health care (e.g., access to 
binders, packers or gaffs, non-medical supplies including makeup and wigs, medical 
materials that are important after surgery). It is possible that some individuals may have 
had reduced access to some of these aspects of care because of the closure of non-
essential stores during peak periods of the pandemic. The TransCare Covid-19 project 
reported relatively similar findings to our study, with 12.4% of TGNB persons in their 
sample reporting restricted access to binders and packing material, and 16.3% had 
restricted access to non-medical supplies (Koehler et al., 2020). A global study, that 
predominantly had participants from Europe and Southeast Asia, reported that among 
those who were using gender-affirming care services before the onset of the pandemic, 
31.1% had reductions in surgical aftercare materials, 36.6% had reductions in cosmetic 
supplies and services, with 33.3% reporting a reduction in access to body modifiers, 
including binders and packing materials (Restar et al., 2021). This means that reductions 
in cosmetic supplies and services and body modifiers was double that of what was 
reported in our sample for those aspects of gender-affirming healthcare. Moreover, 
reductions in surgical aftercare were also much higher in the global study compared to 
our study (31.1% vs. 6.1%).  
It is possible that income loss was higher in some European and South-East Asian 
countries compared to Canada, which in turn may have reduced access to some aspects of 
gender-affirming healthcare. For example, the study by Restar et al. (2021) reported that 
due to the pandemic, almost three fourths of their sample anticipated a reduced income. 
In Canada, CERB was quickly provided to financially support individuals who were 
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impacted by the COVID-19 pandemic, with other forms of financial support that were 
provided as the pandemic progressed (Government of Canada, 2021); financial support to 
this extent may not have been provided in other countries across the globe. Therefore, the 
financial aid provided by the Canadian government might have mitigated the impact of 
the pandemic on financial loss and in turn, reduced its effect on access to certain aspects 
of gender-affirming health care. 
5.1.5 Regression analyses of interruptions in gender-affirming care 
and anxiety 
Three different regression models were used to assess whether that was an association 
between interruptions in gender-affirming care and pandemic anxiety. The first model, 
which included interruptions in gender-affirming care as a predictor of pandemic anxiety 
(adjusting for pre-pandemic anxiety), revealed that there was no significant relationship 
between interruptions in gender-affirming care and pandemic anxiety. The R2 value was 
relatively high (R2= 0.4747) indicating that 47.47% of the variation in pandemic anxiety 
was explained by the independent variables. The second model adjusted for confounders 
and included an interaction term as it was suspected that pre-pandemic anxiety levels 
might modify the relationship between the exposure and outcome. The third and final 
model assessed for an association between interruptions in gender-affirming care and 
pandemic anxiety with adjustment of confounders. After adjustment, it was determined 
that there still was no significant association between interruptions in gender-affirming 
care and pandemic anxiety. This was surprising given that previous literature has 
determined positive associations between receiving gender-affirming care and improved 
mental health (Almazan & Keuroghlian, 2021; Baker et al., 2021; Wernick et al., 2019; 
White Hughto & Reisner, 2016; Passos et al., 2020). Considering that individuals who 
seek gender-affirming care are likely experiencing heightened mental health challenges, 
such as increased anxiety severity related to gender dysphoria, we hypothesized that 
interruptions would likely affect anxiety levels during the pandemic; however, this was 
not a finding in our study. Moreover, the R2 value increased slightly from the first model 
to the third model (R2=0.5489 vs R2=0.4747), indicating that collectively, the additional 
independent variables that were added to the third model improved model fit slightly. It 
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would be interesting to assess how much variation in pandemic anxiety is predicted just 
by pre-pandemic anxiety levels, which was not investigated in our study.  
Similar to our findings, a U.S. longitudinal cohort study of TGNB individuals did not 
find a significant relationship between interruptions in gender-affirming care and greater 
pandemic psychological distress, after adjusting for pre-pandemic psychological distress. 
The authors in this study suggested that it is possible that there was no significant 
association because pre-pandemic psychological distress might be a stronger predictor of 
heightened psychological distress during the pandemic (Kidd et al., 2020). Therefore, it is 
possible that in our study, pre-pandemic anxiety was also a stronger predictor of 
pandemic anxiety levels. In contrast to our study, a global cross-sectional study revealed 
that there was a relationship between screening positive for anxiety and reduced access to 
at least one or more gender-affirming resources (Jarrett et al., 2021). It is possible that the 
investigators in this study found a significant relationship simply because they were 
unable to control for pre-pandemic anxiety levels. It is also possible that participants in 
their sample experienced multiple sources of reduced access to gender-affirming care 
(which were included when examining this relationship), whereas our study solely looked 
at hormonal and surgical interruptions to assess this relationship. 
5.1.6 Regression analyses of interruptions in gender-affirming care 
and depression 
In the final model for the depression outcome, variables encoding interruptions in taking 
hormones, pre-pandemic depression, and their interaction all remained statistically 
significant after confounders were controlled. This is not surprising considering there is 
previous research that has demonstrated the improvements in mental health outcomes 
upon receiving gender-affirming care (Almazan & Keuroghlian, 2021; Baker et al., 2021; 
Wernick et al., 2019; White Hughto & Reisner, 2016; Passos et al., 2020). Hormonal 
interruptions could lead to an unwanted change in secondary sex characteristics and 
therefore heighten gender dysphoria.  
The interaction term between interruptions in taking hormones and pre-pandemic 
depression became statistically significant in the adjusted model; therefore, the 
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association between interruptions in hormones and pandemic depression was modified by 
pre-pandemic depression. Every unit increase in pre-pandemic depression score resulted 
in the pandemic depression score decreasing by 0.16 points for individuals who 
experienced hormonal interruptions. The effect of interruptions in hormonal care on 
pandemic depression was greater for those who had lower pre-pandemic depression 
levels. In comparison, the effect of hormonal interruptions was smaller for those who had 
higher pre-pandemic depression scores. This might be the case because for those who 
already had high pre-pandemic depression levels, their pandemic depression scores could 
only increase to a certain extent since their score was already high. Contrary to our 
hypothesis, after adjustment for confounders, all variables representing the association of 
surgical interruptions or both surgical and hormonal interruptions, pre-pandemic 
depression, and their interaction remained insignificant. It is possible that there was no 
relationship between having a surgical interruption and pandemic depression because 
TGNB persons were much more understanding of their surgery appointments being 
postponed as the country was in a state of emergency, and there was a potential of 
extreme hospital overcrowding with COVID-19 patients. The R2 value increased for the 
final multiple linear regression model, demonstrating that the model fit improved with the 
addition of the covariates (R2 = 0.4900).  
A global cross-sectional study determined that there was a relationship between screening 
positive for depression and reduced access to gender-affirming resources due to the 
pandemic (Jarrett et al., 2021); this aligns with our study findings. In contrast, our 
findings were different from the U.S. longitudinal study conducted by Kidd et al. (2021); 
they did not find a significant relationship between interruptions in gender-affirming care 
and greater psychological distress after adjusting for pre-pandemic mental health levels. 
Considering that the sample size for their study was much smaller, it is possible that they 
did not have adequate power to detect a significant association (Kidd et al., 2021); this 
might explain why their results vary from the findings in this study. 
5.2 Strengths and limitations 
Researchers have called for more studies to longitudinally examine how impacts of the 
COVID-19 pandemic have affected TGNB mental health (Restar et al., 2021). One 
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strength of this study is that we were able to longitudinally examine associations, since 
data were collected both before and after the onset of the pandemic. This allowed us to 
establish causal inferences when examining whether interruptions in gender-affirming 
care were associated with changes in anxiety and depression levels. To our knowledge, 
there are only a few studies that have collected data on anxiety and depression both pre-
pandemic and during the pandemic among TGNB persons. Most were instead cross-
sectional study designs, making it difficult to establish any causal inferences in terms of 
mental health changes. Also, the sample used data from the Trans PULSE Canada study 
which is the first of its kind to collect data on TGNB health and wellbeing across age 
groups and provinces/territories in Canada. To our knowledge, Canada does not have a 
major dataset that has addressed the experiences of LGBTQ2+ Canadians during the 
pandemic, which may be because data on sexual orientation and gender identity are 
lacking in COVID-19 research efforts. As a result, this study is the first national study 
that has examined whether interruptions in gender-affirming care due to COVID-19 was 
associated with changes in anxiety and depression among TGNB Canadians. This study 
also described how the pandemic impacted transgender-specific healthcare across 
Canada, which has not yet been reported in other studies. Another advantage is that our 
study included a relatively large number of participants who identified as non-binary, 
genderqueer, agender or a similar identity which has previously been recognized as an 
understudied population (Motmans et al., 2019). Lastly, our study included individuals 
aged 15 and older which increases the generalizability of our results to many different 
age groups.  
It is important to note that there are limitations present in this study. First, the participants 
in this sample were generally highly educated, which was expected considering the 
Canadian population is one of the most educated populations in the world (Statistics 
Canada, 2017b). As such, it is possible that less educated persons in the community 
might not be represented in this sample and thus, the COVID-19 impacts reported in this 
study might underestimate what was truly experienced for those individuals. Given the 
relationship between intersectionality and structural inequality, TGNB persons who also 
belong to other minority or marginalized groups, including racial and ethnic minority 
groups, might be disproportionately affected by COVID-19 (Bowleg, 2020). Due to the 
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small proportion of participants who identified or were perceived as people of colour in 
our TGNB sample, our results may not be generalizable to individuals who belong to 
more than one marginalized group and experience multiple sources of oppression. Most 
of our respondents also lived in densely populated provinces (e.g., Ontario) and urban 
areas; therefore, the findings might be more reflective of persons living in those areas. 
The Trans PULSE Canada team recontacted 1184 participants to complete the 2020 
questionnaire and had a total of 826 survey respondents. After the removal of six 
observations, the final sample size for the 2020 COVID-19 survey was 820. Although the 
retention rate was relatively high and weights were used to try and reduce biases related 
to survey completion, there is a possibility that differential attrition could have impacted 
the study results if individuals who were most impacted by the pandemic were the least 
likely to complete the 2020 questionnaire (Kidd et al., 2021). Conversely, there is also a 
possibility that those who were heavily impacted by the pandemic were more likely to 
complete as the 2020 COVID-19 questionnaire was more relevant to them. Additionally, 
the data collected were self-reported which might influence participants to respond to 
questions in a manner that is more socially desirable. For example, there is often stigma 
surrounding the topic of mental health and as such participants might choose to 
underreport their anxiety and depression symptoms.  
Another limitation was the small sample size for certain interruption in gender-affirming 
care groups. Specifically, there were only 23 and 18 participants in the interruptions in 
surgery and interruptions in surgery and hormones groups, respectively. Although these 
groups are quite small, they were not grouped together because they were qualitatively 
different. We hypothesized that hormonal interruptions would have more of an effect on 
depression and anxiety than surgical interruptions. Surgery interruptions were happening 
across the country for various populations, as such TGNB persons might be more 
understanding of this type of delay as there was a global hospital crisis. In contrast, 
interruptions in hormones will affect TGNB persons’ wellbeing almost immediately. On 
the other hand, surgical interruptions were likely to last longer than hormonal 
interruptions and this could also have an influence on anxiety and depression levels. 
Therefore, there was no a priori knowledge to suggest that interruptions in surgery and 
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hormones should be grouped with the surgical interruption group instead of the hormonal 
interruption group. Nevertheless, the results should be interpreted with caution because 
the small sample sizes in these two groups likely resulted in reduced power, which might 
have affected the ability to determine a significant association. The small sample sizes 
could also affect the reliability or precision in our regression estimates.  
Our study was conducted in the fall of 2020 however the COVID-19 pandemic was 
declared in March (2020). It is possible that by the time the questionnaire was 
administered, hormonal interruptions could have already been resolved. From the data 
that were collected, it was not possible to know how long or the exact time period that 
participants experienced certain interruptions. Instead of asking respondents about their 
mental health during the specific time periods that they may have had interruptions, 
anxiety and depression levels were measured at the time of taking the questionnaire. 
Therefore, it is possible that pandemic anxiety and depression levels reported were not 
reflective of the mental health levels when the actual interruption in care had been 
experienced. Another limitation in our study is that participants may have misinterpreted 
the question pertaining to interruptions in hormones in which those who had “intentional 
interruptions” may have been included, whereas the focus of this study was only on those 
who had “unintentional interruptions.” However, we tried to reduce this as much as 
possible by going through the “other” reasons for inability to access hormones and re-
coding obvious intentional interruptions (e.g., choosing to discontinue or trying to 
conceive) as no interruptions in hormones.  
Residual confounding may have also been present in our study. A DAG was used to 
determine the minimum sufficient set of confounders to adjust for in order to measure an 
unbiased association between our exposure and outcomes. Previous literature and a priori 
knowledge were used for guidance in creating the DAG. Given the limited research 
available on this novel topic, it is possible that additional, unidentified confounding 
factors may not have been considered. Also, the survey data that were used to measure 
the confounding variables may not have been measured precisely; this could lead to 
residual differences between interruptions in care groups which could ultimately bias the 
results (Dekkers et al., 2019). 
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5.3 Future research 
This study was able to describe the COVID-19 pandemic impact on access to gender-
affirming healthcare, while also examining how interruptions in hormones and surgeries 
affected anxiety and depression in Canada. Future studies should focus on assessing the 
relationship between disruptions in post-operative care after recent gender-affirming 
surgeries and mental health, as complications with surgery aftercare might have a 
detrimental impact on TGNB health and well-being. Our study found that there was no 
relationship between interruptions in care and pandemic anxiety; it would be interesting 
to qualitatively explore why the pandemic might have improved or had a reduced impact 
on anxiety in TGNB populations. It would also be useful to investigate what interventions 
might mitigate the impact of the pandemic on TGNB access to gender-affirming 
healthcare in case of a future resurgence in COVID-19 cases and further restrictions. 
Future research should also focus on examining whether the changes in depressive 
symptoms observed in this study were long-term or resolved. Mental health should 
continue to be monitored throughout and after the pandemic to be able to determine 
whether there are long-term effects of the pandemic on the mental health of TGNB 
persons.  
For groups with small sample sizes, it is difficult to quantitatively analyze intersections. 
Therefore, oversampling small groups might be beneficial to create intersections that are 
large enough for analysis; this would allow researchers to investigate the pandemic 
effects on individuals with intersecting identities. With a better understanding of how the 
pandemic has affected these individuals, new interventions and policies can be 
established to help reduce inequalities that might be present for persons that belong to 
more than one marginalized group. Also, most COVID-19 data that are available for 
TGNB persons were collected via online questionnaires; future studies should focus on 
potentially incorporating multimode research in order to reach very low-income or less 
educated TGNB people in Canada. Moreover, more research needs to be conducted 
globally to have a better understanding on how the pandemic may have affected or 
continues to affect access to gender-affirming healthcare during the pandemic. With 
many services offered online due to COVID-19, exploring TGNB individuals’ experience 
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with virtual, mental health services would provide practical feedback to mental health 
service providers, which might improve virtual healthcare that is provided to this 
community in the future.  
Overall, TGNB communities experience high levels of anxiety and depression, and 
interruptions in gender-affirming care may have increased depressive symptoms in an 
already highly-depressed group. This is very concerning considering the relationship 
between anxiety and depression and suicide risk. It is important to investigate whether 
pandemic-related interruptions and changes have resulted in higher suicidal ideation and 
behaviour, along with self-harm risks in order to implement necessary interventions that 
could help at-risk populations, including the TGNB community. Moreover, with the rapid 
emergence of different variants, it is possible that the pandemic may not be coming to an 
end anytime soon. As a result, it is important for policy makers to ensure that the impact 
of pandemic-related changes, including interruptions in gender-affirming care for TGNB 
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Welcome to the survey! These first questions are meant to give you a chance to tell us some basic 
information about yourself. 
 
1. How old are you?   
__________ years old 
2.  Which of the following reflect your ethno-racial background? (Please check all that 
apply) 
❑ Black African (e.g. Ghana, Kenya, Somalia) 
❑ Black Canadian or African-American 
❑ Black Caribbean (e.g., Jamaica, Haiti) 
❑ East Asian (e.g. China, Japan, Korea, Taiwan) 
❑ Indigenous (e.g. First Nations, Metis, Inuit, Native American) 
❑ Indo-Caribbean (e.g. Guyanese with origins in India) 
❑ Jewish 
❑ Latin American (e.g. Argentina, Mexico, Nicaragua) 
❑ Middle Eastern (e.g. Egypt, Iran, Israel, Saudi Arabia) 
❑ South Asian (e.g. India, Sri Lanka, Pakistan) 
❑ South East Asian (e.g. Vietnam, Malaysia, Philippines) 
❑ White Canadian or White American 
❑ White European (e.g. England, Greece, Sweden, Russia)  
❑ Other, please specify: _________________________________ 
 
Please answer the next question only if you selected “Indigenous” above. Otherwise, please 
skip to #3. 
2a.  Are you…? (Please check all that apply) 
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❑ First Nations (status) 
❑ First Nations (non-status) 
❑ Métis  
❑ Inuk 
❑ Indigenous from Canada, don’t know which group 
❑ Indigenous from another country 
 
❑ Unsure 
3. Are you perceived or treated as a person of colour in Canada? 
 Yes 
 No 
4. Do you identify as a person of colour? 
 Yes 
 No 
5. What country were you born in? 
 Canada → Skip to #7 
 Outside of Canada, please specify country: ___________________________ 
 Unsure  
6. How long have you been living in Canada?    
 ________ years and  _______ months  
7. What province or territory do you currently live in? 
 Alberta 
 British Columbia 
 Manitoba 
 New Brunswick 
 Newfoundland and Labrador 
 Nova Scotia 
 Ontario 





 Northwest Territories 
 Nunavut 
 Yukon 
8. Have you been living in your current province/territory since March 12, 2020? 
 Yes 
 No 
9. What is the postal code where you live or get mail? 
 My postal code is:  __ __ __ __ __ __ 
 I don’t know my postal code 
 I would rather not share my full postal code. The first three digits are: __ __ __ 
 
10. What is the highest level of formal education you have completed?  
 Some high school, no diploma or GED 
 GED 
 High school graduate 
 Some CÉGEP, no diploma 
 CÉGEP graduate 
 Some college or trade school, no degree 
 College or trade school graduate 
 Some university, no degree 
 Bachelor’s degree 
 Some graduate work, no degree 
 Master’s degree (e.g. MA, MS, MBA) 
 Doctoral or professional degree (e.g. PhD, MD, JD) 
11. Are you currently enrolled as a student? 
 Yes, full-time 
 Yes, part-time 
 No 









❑ Straight or Heterosexual 
❑ Two-Spirit 
❑ Not sure or questioning 




The next questions are about sex and gender. The response categories might not be a perfect fit 
for you, which is why we also want to know how you self-identify! 
 
13. What term(s) do you use to describe your gender? 
___________________________________________ 
14. What sex were you assigned at birth, meaning on your original birth certificate?  
 Male 
 Female 
15. If you had to select ONE response that best describes your current gender identity for the 
purposes of a survey, what would it be?  
 Man or boy 
 Woman or girl  
 Indigenous or other cultural gender identity (e.g., two-spirit) 
 Non-binary, genderqueer, agender, or a similar identity  
Income 
 




In the next sections, we’ll ask about experiences you may have had in the past 12 months (since 
today’s date in September 2019), and since March 12, 2020 - the day after the World Health 
Organization declared COVID-19 to be a pandemic. We need to ask about both of these 
timeframes to compare to how you answered the same questions in 2019, and to understand what 
has changed since the pandemic.  
 
Next we are going to ask a few questions about your income, including how your income has 
been affected in recent months. Although a lot of health costs are covered by health insurance, 
there is still a relationship between our health and our incomes. Please know that, like all other 
information you have provided, these answers will be kept confidential. 
We recognize that, as a community, we work in all types of fields. When we talk about work and 
income, we are talking about all types of income-generating activity, both formal and informal 
employment. This includes work from public speaking to sex work to child care. 
16. What is your best estimate of the total income from all members living in your household 
including yourself, before taxes and deductions, from all sources in in 2019? (Include any 
money your household received from any person or organization.) By household 
members, we mean people with whom you share income and resources, or who share 
income and resources with you. 
 Less than $10,000 
 $10,000 to less than $15,000 
 $15,000 to less than $20,000 
 $20,000 to less than $30,000 
 $30,000 to less than $40,000 
 $40,000 to less than $50,000 
 $50,000 to less than $60,000 
 $60,000 to less than $80,000 
 $80,000 to less than $100,000 
 $100,000 to less than $150,000 
 $150,000 or more 
 Unsure 
17. Including yourself, how many people (in or outside of Canada) were being supported on 
this income?  
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________ people  
18. What is your best estimate of your total personal income, before taxes and other 
deductions from all sources in 2019? (include any money you received from any person 
or organization) 
 I didn’t have a personal income 
 Less than $10,000 
 $10,000 to less than $15,000 
 $15,000 to less than $20,000 
 $20,000 to less than $30,000 
 $30,000 to less than $40,000 
 $40,000 to less than $50,000 
 $50,000 to less than $60,000 
 $60,000 to less than $80,000 
 $80,000 to less than $100,000 
 $100,000 to less than $150,000 
 $150,000 or more 
 Unsure 
 
19.   Before March 12, 2020, were you receiving any income from the following sources? 
 Public social assistance or welfare 
 Public disability support 
 Both public social assistance/welfare and disability support 
 I did not receive income from either of these sources 
 
20. Since March 12, 2020 did you receive any income from the following sources?  
 Public social assistance or welfare 
 Public disability support 
 Both public social assistance/welfare and disability support 
 I did not receive income from either of these sources 
 
21.  Since March 12, 2020, did you receive any of the following types of Employment 





❑ Caregiving or compassionate care 
❑ Work-sharing 
❑ Other Employment Insurance benefit 
❑ Canada Emergency Response Benefit (CERB) 
❑ Canada Emergency Student Benefit (CESB) 
❑ Did not receive any benefits 
 
22. Since March 12, 2020, how much income have you received from government funded 
COVID-19 relief programs (including rent relief)? 
$________  
❑ I did not receive any relief  
 
23.  Which of the following best describes the impact of COVID-19 on your ability to meet 
financial obligations or essential needs, such as rent or mortgage payments, utilities and 
groceries? 
 Major negative impact 
 Moderate negative impact 
 Minor negative impact 
 No impact 
 Minor positive impact 
 Moderate positive impact 
 Major positive impact 
 Too soon to tell 
 
24. Which of the following best describes the impact of COVID-19 on your ability to make 
rent or mortgage payments? 
 Major negative impact 
 Moderate negative impact 
 Minor negative impact 
 No impact 
 Minor positive impact 
 Moderate positive impact 
 Major positive impact 
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 Too soon to tell 
 
25. Which of the following statements best describes the food eaten in your household since 
September 2019?   
 You and your household always had enough of the kinds of food you wanted to eat 
 You and your household had enough to eat, but not always the kinds of food you 
wanted 
 Sometimes you and your household did not have enough to eat 
 Often you and your household didn’t have enough to eat 
 
26.  Which of the following statements best describes the food eaten in your household since 
March 12, 2020?   
 You and your household always had enough of the kinds of food you wanted to eat 
 You and your household had enough to eat, but not always the kinds of food you 
wanted 
 Sometimes you and your household did not have enough to eat 
 Often you and your household didn’t have enough to eat 
 
If you are not yet 16 years old, please skip to the Indigenous Well-Being section (#36 on page 




27. Before March 12, 2020, which of the following best described your personal employment 
situation? (Please check all that apply) 
❑ Employed in a permanent full-time position (30 hours or more per week) 
❑ Employed in a permanent part-time position (less than 30 hours per week) 
❑ Employed on temporary/short term contract (less than a year)  
❑ Employed on a fixed term contract, one year or more  
❑ Self-employed – no employees  
❑ Self-employed – others work for me  
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❑ Worked for pay in the informal economy (e.g. paid in cash or “under the table” in 
restaurant or construction)  
❑ Not employed 
❑ Student 
❑ Retired 
❑ On leave 
❑ Other, specify: _________________________________ 
❑ None of the above  
 
28. Which of the following best describes your current personal employment situation? 
(Please check all that apply) 
❑ Employed in a permanent full-time position (30 hours or more per week) 
❑ Employed in a permanent part-time position (less than 30 hours per week) 
❑ Employed on temporary/short term contract (less than a year)  
❑ Employed on a fixed term contract, one year or more  
❑ Self-employed – no employees  
❑ Self-employed – others work for me  
❑ Work for pay in the informal economy (e.g. paid in cash or “under the table” in 
restaurant or construction)  
❑ Not employed 
❑ Student 
❑ Retired 
❑ On leave 
❑ Other, specify: _________________________________ 
❑ None of the above  
 
29.  As a result of the COVID-19 pandemic, has your employment situation changed in any of 
the following ways? (Please check all that apply) 
❑ Still working, but working less (e.g., lost one of my jobs, reduced hours) 
❑ Not working, I have lost my job or jobs 
❑ Temporarily laid-off 
❑ Start date has been delayed 
❑ Lost a job that I was supposed to start in the future 
❑ No longer have employment prospects 
❑ Currently looking for work 
❑ No longer looking for work 
❑ Working more 




30. How much of an impact did the COVID-19 pandemic have on your personal income 
from employment?  
 Major negative impact 
 Moderate negative impact 
 Minor negative impact 
 No impact 
 Minor positive impact 
 Moderate positive impact 
 Major positive impact 
 Too soon to tell 
 
31. Since March 12, 2020, has there been a time when you experienced a total loss of 
personal income from employment? 
 Yes 
 No  
 
32. Since September 2019, have you done sex work or exchanged sex for money or other 
resources (e.g. shelter, substances, food, or other services)? 
 Yes 
 No → Skip to #33 
 
 32a. Have you done sex work since March 12, 2020? 
 Yes 
 No → Skip to #33 
 
32b. Have you seen sex work clients in person since March 12, 2020? 
 Yes 
 No  
 





 I’m not working currently 
 
34. Are you an essential service worker (healthcare, grocery store staff, etc.)? 
 Yes 
 No → Skip to #35 
 Unsure 
 
34a. Which of the following sectors best captures your job? 
 Health care or public health 
 Grocery store 
 Food service 
 Other, please specify: __________________________________ 
 
35. Since March 12, 2020, have you started a new job because of COVID-19? 
 Yes 
 No  
Indigenous Well-Being 
If you are not Indigenous, please skip to the Your Health section on page 10. 
 
 
The next few questions are about ways that Indigenous trans, two-spirit, non-binary, and gender 
diverse people are staying healthy during the pandemic. These questions were developed by the 
team’s Indigenous Leadership Group. 
 
36.       Are you a part of an Indigenous community? This could be online or in person. 
 Yes 




36a.  Since March 12, 2020, has your access to Indigenous community gatherings 
(online or in person)… 
 Increased 
 Stayed the same 
 Decreased 
 
37.       Can you describe any ways you are staying connected to Indigenous community 











38.       Before March 12, 2020, did you participate in ceremony? 
 Yes 
 No → Skip to #39 
 




 No → Skip to #39 
 














The next few questions are about your health right now. 
 
39. In general, would you say your health is…?  
 Excellent 







40.  Do you have a compromised immune system?  
 Yes 
 No  
41.  Do you have diabetes or a chronic condition affecting your lungs, heart or kidneys?  
 Yes 




The next few questions are about disabilities. We acknowledge that disability is a very broad 
category that can include many realities and experiences. Some people who might be labelled 
under disability categories might not identify as living with a disability.  
*Note: Episodic disabilities are long-term conditions that are characterized by periods of good 
health interrupted by periods of illness or disability). These may include, but are not limited to 
asthma, arthritis, and HIV. 
 
42. Do you self-identify as someone who currently lives with the following realities or 





❑ Disabled or living with a disability (including episodic disability*) 
❑ Chronic pain 
❑ Chronic illness 
❑ Chronic health condition 
❑ Neurodivergent  
❑ Psychiatric survivor, mad, or person with mental illness 
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❑ Another disability identity not listed here:  _______________________ 
❑ None of the above  
 
43. Have you been diagnosed with any of the following? (Please check all that apply) 
❑ Acquired brain injury 
❑ Autism or Asperger’s 
❑ Chronic Illness 
❑ Chronic pain condition 
❑ Intellectual or developmental disability  
❑ Intermittent or episodic illness or condition 
❑ Learning disability 
❑ Mobility or physical disability 
❑ Vision impairment  
❑ Mental health condition  
❑ Another condition or disability not listed here : 
________________________________ 
❑ None of the above 
 
COVID-19 Testing, Diagnosis, and Care 
 
In the next few questions, we would like to ask you about symptoms, testing, and treatment of 
COVID-19. 
44. When a COVID-19 vaccine becomes available, how likely is it that you will choose to 
get it? 
 Very likely → Skip to #46 
 Somewhat likely 
 Somewhat unlikely 
 Very unlikely 
 Unsure 
 




❑ Already had or think I have had COVID-19 
❑ Do not consider it necessary to get the vaccine 
❑ Not confident in the safety of the vaccine 
❑ Do not believe in vaccination 
❑ Concern about risks and side effects 
❑ Have a pre-existing medical condition 
❑ Will wait until it seems safe to get the vaccine 
❑ Have not yet decided 
❑ Other reason, please specify: ________________________________ 
❑ Unsure 
 
46. Have you wanted to get tested for COVID-19, but been unable to? 
 Yes 
 No → Skip to #47 
 





















47. Have you avoided COVID-19 testing or care when you thought you needed it? 
 Yes 
 No → Skip to #48 
 
47a. Have you avoided COVID-19 testing or care because of fear of discrimination as 
a trans or non-binary person? 
 Yes 
 No  
 













48.  Have you been tested for COVID-19 with a swab since March 12, 2020? 
 Yes 
 No → Skip to #50 
 









49.  Have you been diagnosed with COVID-19? 
 Yes 
 No → Skip to #50 
 
49a. In what month were you diagnosed? 
 March  
 April  
 May  
 June  
 July  
 August  
 September  
 
50. Regardless of whether you have been diagnosed with COVID-19, do you think you have 
had COVID-19 symptoms? 
 Yes → Skip to #52 
 No  
 Unsure 
 




 Yes → Skip to #53 
 No → Skip to #53 
 Unsure → Skip to #53 
 
52.  How severe are/were your symptoms and how did you manage them? 
 No symptoms → Skip to #53 
 Mild, no significant symptoms 
 Significant symptoms self-managed in quarantine 
 Significant symptoms managed with medical assistance in quarantine 
 Symptoms requiring hospital treatment for ≤ 1 day 
 Symptoms requiring hospital treatment for > 1 day 









52b. How long did your symptoms last? 
________ weeks and ________ days 
52c. Are you still having symptoms now? 
 Yes 
 No  
 
If you have not been tested for COVID-19, or if you have not wanted to be tested for COVID-
19, please skip to #54. 
53. When looking for COVID-19 testing or care, have you experienced discrimination? 
 Yes 




53a.  Did this happen because you’re trans or non-binary? 
 Yes 
 No  
 








Your Mental Health 
 
The next questions are about how you’re doing in terms of mental health and well-being, 
including some questions about suicide and self-harm. 
 
If you need to speak to someone immediately about your mental health, please contact Canada’s 
Trans Life Line (call 877-330-6366), the Indigenous Hope for Wellness Help Line (call 1-855-
242-3310), Crisis Services Canada (call 1-833-456-4566 or text 45645 [call 1-866-277-3553 in 
Quebec]), or Kids Help Phone (call 1-800-668-6868 or text CONNECT to 686868). 
 









55.  Compared to before physical distancing began, how would you say your mental health is  
  now? 
 Much better now 
 Somewhat better now 
 About the same 
 Somewhat worse now 
 Much worse now 
 
56.  Below is a list of the ways you might have felt or behaved. Please tell us how often you  
have felt this way during the past week. 
 
56a. I was bothered by things that usually don’t bother me. 
 
Rarely or none of the 
time (less than 1 day) 
 
Some or a little of the 
time (1-2 days) 
 
Occasionally or a 
moderate amount of 
time (3-4 days) 
 







56b. I had trouble keeping my mind on what I was doing. 
Rarely or none of the 
time (less than 1 day) 
 
Some or a little of the 
time (1-2 days) 
 
Occasionally or a 
moderate amount of 
time (3-4 days) 
 




56c. I felt depressed. 
Rarely or none of the 
time (less than 1 day) 
 
Some or a little of the 
time (1-2 days) 
 
Occasionally or a 
moderate amount of 
time (3-4 days) 
 




56d. I felt that everything I did was an effort. 
Rarely or none of the 
time (less than 1 day) 
 
Some or a little of the 
time (1-2 days) 
 
Occasionally or a 
moderate amount of 
time (3-4 days) 
 




56e. I felt hopeful about the future. 
Rarely or none of the 
time (less than 1 day) 
 
Some or a little of the 
time (1-2 days) 
 
Occasionally or a 
moderate amount of 
time (3-4 days) 
 






56f. I felt fearful. 
Rarely or none of the 
time (less than 1 day) 
 
Some or a little of the 
time (1-2 days) 
 
Occasionally or a 
moderate amount of 
time (3-4 days) 
 




56g. My sleep was restless. 
Rarely or none of the 
time (less than 1 day) 
 
Some or a little of the 
time (1-2 days) 
 
Occasionally or a 
moderate amount of 
time (3-4 days) 
 




56h. I was happy. 
Rarely or none of the 
time (less than 1 day) 
 
Some or a little of the 
time (1-2 days) 
 
Occasionally or a 
moderate amount of 
time (3-4 days) 
 




56i. I felt lonely 
Rarely or none of the 
time (less than 1 day) 
 
Some or a little of the 
time (1-2 days) 
 
Occasionally or a 
moderate amount of 
time (3-4 days) 
 






56j. I could not get “going.” 
Rarely or none of the 
time (less than 1 day) 
 
Some or a little of the 
time (1-2 days) 
 
Occasionally or a 
moderate amount of 
time (3-4 days) 
 




57.  The following items ask about anxiety and fear. For each item, please select the answer  
that best describes your experience over the past week. 







57b. When you feel anxious, how intense or severe is your anxiety? 






57c. How often do you avoid situations, places, objects, or activities because of 






57d.  How much does anxiety or fear interfere with your ability to do the things you 
need to do at work, at school, or at home? 








57e. How much does anxiety or fear interfere with your social life and relationships? 






The next questions are about suicide and self-harm. 
If you need to speak to someone immediately about your mental health, please contact Canada’s 
Trans Life Line (call 877-330-6366), the Indigenous Hope for Wellness Help Line (call 1-855-
242-3310), Crisis Services Canada (call 1-833-456-4566 or text 45645 [call 1-866-277-3553 in 
Quebec]), or Kids Help Phone (call 1-800-668-6868 or text CONNECT to 686868). 
58.  Since September 2019, have you done anything to hurt yourself on purpose? For 
example, cutting, burning, scratching, or hitting yourself. 
 Yes 
 No → Skip to #59 
58a. Has this happened since March 12, 2020? 
 Yes 
 No  
 
59. Since September 2019, have you seriously considered suicide?   
 Yes 
 No → Skip to #60 





60. Since September 2019, have you attempted suicide?  
 Yes 
 No → Skip to #61 
 60a.  Since March 12, 2020, have you attempted suicide? 
 Yes 
 No → Skip to #61  
If you need to speak to someone immediately about your mental health, please contact Canada’s 
Trans Life Line (call 877-330-6366), the Indigenous Hope for Wellness Help Line (call 1-855-
242-3310), Crisis Services Canada (call 1-833-456-4566 or text 45645 [call 1-866-277-3553 in 
Quebec]), or Kids Help Phone (call 1-800-668-6868 or text CONNECT to 686868). 
 
 
61. Before March 12, 2020, were you receiving mental health support from a community 




62. Since March 12, 2020, have you received mental health support from a community 




63.  Before March 12, 2020, were you talking to a therapist or mental health care professional 




64.  Since March 12, 2020, have you talked to a therapist or mental health care professional 






65.  Since March 12, 2020, have you not received mental health care that you thought you 
needed? 
 Yes 
 No  → Skip to #66 
 I have not needed mental health care during this time → Skip to #66 
 




Next, we’d like to ask you about cigarettes, vaping, and cannabis. 
 
66.   At the present time, do you smoke cigarettes daily, occasionally or not at all?  
 Daily 
 Occasionally  
 Not at all  
 
67.   At the present time, do you vape nicotine / e-cigarettes daily, occasionally or not at all?  
 Daily 
 Occasionally  
 Not at all  
 




 Occasionally  
 Not at all  
 
The next few questions ask about your alcohol consumption. 
When we use the word ‘drink’ it means: 
-  one (1) bottle or can of beer or a glass of draft 
-  one (1) glass of wine or a wine cooler 
-  one (1) drink or cocktail with 1½ ounces of liquor 
69.  How often did you have a drink containing alcohol in the past year? 
 Never → Skip to #72 
 Monthly or less 
 2 to 4 times a month 
 2 to 3 times a week 
 4 or more times a week 
 
70.  How many drinks did you have on a typical day when you were drinking in the past year? 
 1 to 2 
 3 to 4 
 5 to 6 
 7 to 9 
 10 or more 
 
71.  How often did you have 6 or more drinks on one occasion over the past year? 
 Never 
 Less than monthly 
 Monthly 
 Weekly 




72.   In the following question, please indicate which substances you have used since 
September 2019, and whether you used that substance several times a week or more. If 
you have not used a substance, then you don’t have to answer the second question for that 
substance. 
 I have not used any of the listed substances 
  
Since September 





2019, have you 
used this several 
times a week or 
more? 
Heroin and other street opioids  
(e.g., fentanyl, “down”) 




Prescription opioids not prescribed to you  
(e.g., codeine, methadone, oxycodone, 
morphine, fentanyl, hydromorphone, 
tramadol, buprenorphine) 




Cocaine powder or crack 




Ritalin, or another prescription stimulant not 
prescribed to you (e.g. Concerta, Dexedrine, 
Adderall, or Vyvanse) 




Methamphetamine (ice, crystal meth, tina) or 
other amphetamines (speed) 




Sedatives or sleeping pills  
(e.g., zopiclone or benzodiazepines such as 
Xanax, Valium, Serapax, clonazepam)  




Inhalants, glue, solvents 






Synthetic cannabinoids (e.g., K2, Spice) 




Ecstasy (MDA, MDMA) 





(e.g., LSD, acid, mushrooms, PCP) 




Ketamine (Special K) 

















In the next few questions, we would like to learn about your experiences with finding competent 
and respectful health care and social services.  
 
 
73.   Do you currently have insurance that covers all or part of the cost of your prescription 
medications? 
 Yes 
 No  
 Unsure 
 
74. Since September 2019, was there ever a time when you felt that you needed health care, 
other than home care services, but didn’t receive it?  
 Yes 




 74a. Has this happened since March 12, 2020? 
 Yes 
 No  
 
75. Before March 12, 2020, were you receiving home care? 
 
 Yes 
 No → Skip to #76 
 
75a. Since March 12, 2020, have you experienced interruptions or changes to the 
home care services you were receiving? 
 Yes 
 No → Skip to #76 
 
75b. Can you describe the service change or interruptions you experienced, and how 












Virtual and Tele-Health Care  
 
The next questions are about virtual or tele healthcare, meaning health care or medical advice 
delivered via phone call, video call, or text message. 
 
 
76.  Since  March 12, 2020 have you avoided accessing virtual or tele healthcare because 
you're trans or non-binary?  
 Yes 
 No  
 
77. Since March 12, 2020 have you accessed virtual or tele healthcare? 
 Yes 
 No → Skip to #78 
 
77a. Since March 12, 2020, did you receive virtual or tele healthcare via… (Please 
check all that apply) 
❑ Phone call 
❑ Video call 
❑ Text message or other direct messaging service 
❑ Other, please specify: __________________________ 
 
77b. What kind of care did you receive virtually?  (Please check all that apply) 
❑ Physical health care 
❑ Mental health care  
❑ Other, please specify: _________________________  
 
If your answer to 77b was not “physical health care”, please skip to #78. 
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Primary Care  
 
The next questions are about primary care. 
80. Do you currently have a primary health care provider? By this, we mean one health 
professional that you regularly see or talk to when you need care or advice for your 
health. 
 Yes, a family doctor 
 Yes, a nurse practitioner 
 No, I receive primary health care at a walk-in clinic → Skip to #83 




81. Since March 12, 2020 have you seen or spoken to your primary health care provider? 
 Yes 
  No → Skip to #82 
 
If you have not had symptoms of COVID-19, please skip to #82. 
 
81a.  Have you seen or spoken to your primary health care provider about your own 




82.  Since March 12, 2020 have you avoided talking to your primary care provider about any 
health concerns? 
 Yes 
 No → Skip to #83 
 I have not needed primary care during this time → Skip to #83 
 My primary care provider is not seeing non-urgent patients during this time → 





82a.  What were your reasons for avoiding primary care since March 12, 2020? (Please 
check all that apply) 
❑ Concern about being exposed to COVID-19 
❑ My health concern didn’t seem urgent or important enough 
❑ Couldn’t bring a support person to appointments 
❑ Couldn’t access patient navigator 
❑ Concern about how my voice would be perceived over the phone 
❑ Other, please specify: _____________________________ 
Emergency Care  
 
The next questions are about going to the emergency room (ER) for issues concerning your own 
health. 
 
83.  Since September 2019, have you avoided going to the emergency room (when you 
needed care) because you are trans or non-binary? 
 Yes 
 No → Skip to #84 
 I have not needed emergency care during this time → Skip to #85 
 
83a. Did this happen since March 12, 2020?  
 Yes 
 No 
 I have not needed emergency care during this time → Skip to #86 
 
84.  Since March 12, 2020 have you avoided going to the emergency room (when you needed 
care) because you were worried about being exposed to COVID-19? 
 Yes 
 No  




Gender-Affirming Medical Care  
 
In the next questions, we would like to learn about your access to gender-affirming medical care 
during the pandemic. For our purposes, “gender-affirming medical care” refers to puberty 
blockers, gender-affirming hormones, surgeries, and/or body modifications. 
 
85. Which of the following applies to your current situation regarding puberty blockers, 
hormones and/or surgery? (Please check only one)   
 I have had the gender-affirming medical treatment that I need/want  
 I am in the process of completing gender-affirming medical treatment 
 I am planning to receive gender-affirming medical treatment, but have not begun → 
Skip to #87 
 I am not planning to receive gender-affirming medical treatment → Skip to #89 




The next questions are about hormones. When we ask about hormones, this includes puberty 
blockers. 
 
86. Do you take hormones? 
 Yes  
 No → Skip to #87 
 
86a.  Right now, do you have access to hormones? 
 Yes  




86b. Since March 12, 2020, have you had interruptions in taking hormones? 
 Yes  
 No → Skip to #87 
 
86c. For what reasons were you unable to access hormones? (Please check all that 
apply) 
❑ Couldn’t afford it 
❑ Couldn’t go to the pharmacy 
❑ Couldn’t get my prescription renewed 
❑ Couldn’t get syringes or needles 
❑ Drug shortages 
❑ Nobody to help with injections 
❑ People in my household couldn’t know I’m taking hormones 
❑ Other, please specify: __________________________________ 
 
If you are currently taking hormones (answered yes to #86), please skip to #89. 
 
87. Since March 12, 2020, have you been unable to get a new prescription or referral for 
hormones? 
 Yes  
 No → Skip to #88 




87a. Did this happen because of restrictions related to COVID-19 (e.g. clinic 
closures)? 
 Yes  
 No 
 
88. Before March 12, 2020, did you have an appointment booked to have a gender-affirming 
surgery in the future? 
 Yes  
 No → Skip to #89 
 
88a.  Have you had a surgery appointment canceled or postponed due to the current 
COVID-19 outbreak? 
 Yes 
 No → Skip to #89 
 Not yet, but I expect it will → Skip to #89 
 
88b.  Was an alternative date set for this surgery? 
 Yes 
 No  
 
88c. What kind of surgery was cancelled or postponed? (Please check all that apply) 
❑ Chest surgery, please specify: ____________________________  
❑ Genital gender-affirming surgery, please specify: _________________________ 
❑ Removal of uterus (hysterectomy) or removal of ovaries (oophorectomy)  
❑ Voice surgery  
❑ Adam’s apple surgery 
❑ Facial surgery  
❑ Other, please specify: ________________________________________________ 
 
88d. Have you had this surgery yet? 
 Yes 




89.  Has the current COVID-19 outbreak limited your access to the following aspects of 
gender-affirming health care? 
89a.  Binders, packers, or gaffs 
 Yes 
 No  
 Not applicable 
 
89b. Non-medical supplies (e.g. makeup, shaving supplies, wigs)  
 Yes 
 No  
 Not applicable 
 
89c. Medical material that is important after surgery (e.g. vaginal dilators, chest 
compress) 
 Yes 
 No  
 Not applicable 
 
89d. Post-operative care following gender-affirming surgery 
 Yes 
 No  
 Not applicable 
 
90. At any point since March 12, 2020, have you needed any of the following services, but 
been unable to access them because of the COVID-19 pandemic? (Please check all that 
apply) 
❑ Dental care 
❑ Optometry or ophthalmology 
❑ Physical therapy or chiropractic care 
❑ Religious or spiritual practice 
❑ Activity groups for youth 
❑ Child care  
❑ Immigration or settlement services 
❑ Legal services 
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❑ Other, please specify: ________________________________ 
❑ None of the above 
Your Household 
 
Next we’re going to ask some questions about your living arrangements, and household members. 
Household members are people you live with, or people who live with you.  
 
 
91. What is your legal marital status right now?  




 Living common-law  
 Married 
 
92. On March 12, 2020, what were your living arrangements? (Please check all that apply) 
 Housing you own or rent 
 Temporarily with someone who pays for housing 
 Permanently with someone who pays for housing 
 Shelter, motel, in a car, or other unstable housing 
 Institutional housing (e.g. long-term care, military housing, prison) 
 Other, please specify: __________________________________ 
 
93. What are your current living arrangements? (Please check all that apply) 
 Housing you own or rent 
 Temporarily with someone who pays for housing 
 Permanently with someone who pays for housing 
 Shelter, motel, in a car, or other unstable housing 
 Institutional housing (e.g. long-term care, military housing, prison) 














96. For reasons related to the COVID-19 pandemic, have you lived with a household member 




97.   In general, how supportive of your gender identity or expression are the following 











97a. Your parent(s) or 
guardian(s) 
      
97b. Your spouse or partner(s)       
97c. Your child(ren)       





98.  Excluding members of your household, how many people in total did you come in close 
contact with yesterday?  
'Close contact' means within 2 meters or 6 feet. Include any people such as co-workers, 
relatives, neighbours, delivery workers, other shoppers, health professionals and 
restaurant employees. 
 No contact with people outside my household 
 1 to 2 individuals 
 Between 3 to 5 individuals 
 6 or more individuals 
 
99.  Excluding members of your household, how many people in total did you come in close 
contact with during the last 7 days? 
'Close contact' means within 2 meters or 6 feet. Include any people such as co-workers, 
relatives, neighbours, delivery workers, other shoppers, health professionals and 
restaurant employees. 
 No contact with people outside my household 
 Between 1 to 3 individuals 
 Between 4 and 8 individuals 
 Between 9 and 15 individuals 
 16 or more individuals 
 
100. When was the last time you touched another person? 
 
 Today → Skip to #101 
 This week → Skip to #101 
 This month  
 Before March 12, 2020 
 
100a. How much has this lack of human touch bothered you? 
 A lot 
 Somewhat 





The next questions are about intimate partner violence.  
If you need to speak to someone immediately about your mental health, please contact Canada’s 
Trans Life Line (call 877-330-6366), the Indigenous Hope for Wellness Help Line (call 1-855-
242-3310), Crisis Services Canada (call 1-833-456-4566 or text 45645 [call 1-866-277-3553 in 
Quebec]), or Kids Help Phone (call 1-800-668-6868 or text CONNECT to 686868). 
 
 
101.  Since September 2019, has a romantic partner done any of the following towards you? 
(Please check all that apply) 
❑ Insulted, swore, shouted, or yelled at you 
❑ Tried to control who I talked to or where I went 
❑ Threatened to hurt you 
❑ Pushed, shoved, shook, or pinned you down 
❑ Forced or pressured you to engage in a sexual activity when you didn’t want to 
❑ None of the above → Skip to #103 
 
102.  Since March 12, 2020, have these behaviours… 
 Increased 
 Stayed the same 
 Decreased 
 
103.  Since September 2019, have you done any of the following towards a romantic partner? 
(Please check all that apply) 
❑ Insulted, swore, shouted, or yelled at them 
❑ Tried to control who they talked to or where they went 
❑ Threatened to hurt them 
❑ Pushed, shoved, shook, or pinned them down 
❑ Forced or pressured the other person to engage in a sexual activity when they didn’t 
want to 




104.  Since March 12, 2020, have these behaviours… 
 Increased 
 Stayed the same 
 Decreased 
 
Next we’re going to ask about your experiences finding community and support since 
March 12, 2020. 
 
 
105.  Since March 12, 2020, how often do you feel… 
 105a. Left out? 
 Often 
 Some of the time 




 Some of the time 
 Hardly ever 
 
105c. That you lack companionship? 
 Often 
 Some of the time 
 Hardly ever 
 
106. Before March 12, 2020, did you have a peer or friend group of other trans and non-binary 






107.  Since March 12, 2020, has your access to trans and non-binary peer or friend gatherings 
(online or in person)… 
 Increased 
 Stayed the same 
 Decreased 
108.  How often is each of the following kinds of support available to you right now? 
108a. Someone to help you if you were confined to bed? 
None of the time 
 
A little of the time 
 
Some of the time 
 
Most of the time 
 
All of the time 
 
108b. Someone to take you to the doctor if you needed it? 
None of the time 
 
A little of the time 
 
Some of the time 
 
Most of the time 
 
All of the time 
 
108c. Someone to have a good time with? 
None of the time 
 
A little of the time 
 
Some of the time 
 
Most of the time 
 
All of the time 
 
108d. Someone to prepare your meals if you were unable to do it yourself? 
None of the time 
 
A little of the time 
 
Some of the time 
 
Most of the time 
 
All of the time 
 
108e. Someone to help with daily chores if you were sick? 
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None of the time 
 
A little of the time 
 
Some of the time 
 
Most of the time 
 
All of the time 
 
108f. Someone to turn to for suggestions about how to deal with a personal problem? 
None of the time 
 
A little of the time 
 
Some of the time 
 
Most of the time 
 
All of the time 
 
108g. Someone who understands your problems? 
None of the time 
 
A little of the time 
 
Some of the time 
 
Most of the time 
 
All of the time 
 
108h. Someone to love you and make you feel wanted? 
None of the time 
 
A little of the time 
 
Some of the time 
 
Most of the time 
 




The next question is about experiences of discrimination related to the COVID-19 pandemic. 
If you need to speak to someone immediately about your mental health, please contact Canada’s 
Trans Life Line (call 877-330-6366), the Indigenous Hope for Wellness Help Line (call 1-855-
242-3310), Crisis Services Canada (call 1-833-456-4566 or text 45645 [call 1-866-277-3553 in 




109.  Since March 12, 2020, have any of the following things happened to you because of 
COVID-19? (Please check all that apply) 
❑ You were accused of having or spreading COVID-19 
❑ You were blamed for the pandemic 
❑ You were stopped by police or security over social distancing concerns 
❑ Your property was damaged 
❑ You experienced verbal threats or harassment 
❑ You were assaulted 
❑ Other, please specify: _______________________________ 
❑ None of the above → Skip to #110 
 






COVID-19 Concerns and Safety 
Finally, we have some questions about your concerns during the COVID-19 pandemic, and how 
you’re managing to stay safe. 
 
110.  How concerned are you about each of the following impacts of COVID-19? 






 Not at all 
 




 Not at all 
 




 Not at all 
 




 Not at all 
 




 Not at all 
 




 Not at all 
 






 Not at all 
 




 Not at all 
 
111.  Which of the following precautions have you taken to reduce your risk of exposure to 
COVID-19? (Please check all that apply) 
❑ Stocked up on essentials at a grocery store or pharmacy 
❑ Filled prescriptions 
❑ Made a plan for caring for household members who are ill 
❑ Made a plan for other non-household members (e.g., elderly relatives) 
❑ Made a plan for communicating with family, friends and neighbours 
❑ Avoided leaving the house for non-essential reasons 
❑ Used social distancing when out in public (i.e., made changes in your everyday routine to 
minimize close contact with others.) 
❑ Avoided crowds and large gathering 
❑ Avoided indoor public spaces (e.g. bars or restaurants) 
❑ Washed your hands more regularly 
❑ Avoided touching your face 
❑ Cancelled travel 
❑ Worked from home 
❑ Other, please specify: _______________________________ 
❑ None of the above 
112. Which of the following precautions have you wanted to take, but haven’t been able to? 
(Please check all that apply) 
❑ Stocked up on essentials at a grocery store or pharmacy 
❑ Filled prescriptions 
❑ Made a plan for caring for household members who are ill 
❑ Made a plan for other non-household members (e.g., elderly relatives) 
❑ Made a plan for communicating with family, friends and neighbours 
❑ Avoided leaving the house for non-essential reasons 
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❑ Used social distancing when out in public (i.e., made changes in your everyday routine to 
minimize close contact with others.) 
❑ Avoided crowds and large gathering 
❑ Avoided indoor public spaces (e.g. bars or restaurants) 
❑ Washed your hands more regularly 
❑ Avoided touching your face 
❑ Cancelled travel 
❑ Worked from home 
❑ Other, please specify: _______________________________ 
❑ I have been able to take the precautions I wanted to 
 
113. Can you tell us how the COVID-19 pandemic has impacted you as a trans or non-binary 
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